BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 803748 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C20H25N7O/c1-5-26(13-12-25(4)20-23-15(2)14-16(3)24-20)19(28)17-8-6-7-9-18(17)27-21-10-11-22-27/h6-11,14H,5,12-13H2,1-4H3 YAXCPEJSTUTBSV-UHFFFAOYSA-N 402043 US10011595, A-1 Orexin receptor type 2 Homo sapiens 36.5 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402043 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402043&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416898 405262034 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803749 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C20H25N7O/c1-5-26(13-12-25(4)20-23-15(2)14-16(3)24-20)19(28)17-8-6-7-9-18(17)27-21-10-11-22-27/h6-11,14H,5,12-13H2,1-4H3 YAXCPEJSTUTBSV-UHFFFAOYSA-N 402043 US10011595, A-1 Orexin/Hypocretin receptor type 1 Homo sapiens 2453 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402043 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402043&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416898 405262034 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803750 CCN(CCNc1nc(C)cc(C)n1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C19H23N7O/c1-4-25(12-11-20-19-23-14(2)13-15(3)24-19)18(27)16-7-5-6-8-17(16)26-21-9-10-22-26/h5-10,13H,4,11-12H2,1-3H3,(H,20,23,24) QSHXFLDCCXLBDS-UHFFFAOYSA-N 402044 US10011595, A-5 Orexin receptor type 2 Homo sapiens 1760 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402044 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402044&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121426957 405262035 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803751 CCN(CCNc1nc(C)cc(C)n1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C19H23N7O/c1-4-25(12-11-20-19-23-14(2)13-15(3)24-19)18(27)16-7-5-6-8-17(16)26-21-9-10-22-26/h5-10,13H,4,11-12H2,1-3H3,(H,20,23,24) QSHXFLDCCXLBDS-UHFFFAOYSA-N 402044 US10011595, A-5 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402044 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402044&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121426957 405262035 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803752 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1cccc(c1)C1CC1 InChI=1S/C21H28N4O/c1-5-25(12-11-24(4)21-22-15(2)13-16(3)23-21)20(26)19-8-6-7-18(14-19)17-9-10-17/h6-8,13-14,17H,5,9-12H2,1-4H3 CIUODAJHLKNPDZ-UHFFFAOYSA-N 402045 US10011595, B-1 Orexin receptor type 2 Homo sapiens 26.4 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402045 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402045&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 146047652 405262036 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803753 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1cccc(c1)C1CC1 InChI=1S/C21H28N4O/c1-5-25(12-11-24(4)21-22-15(2)13-16(3)23-21)20(26)19-8-6-7-18(14-19)17-9-10-17/h6-8,13-14,17H,5,9-12H2,1-4H3 CIUODAJHLKNPDZ-UHFFFAOYSA-N 402045 US10011595, B-1 Orexin/Hypocretin receptor type 1 Homo sapiens 2727 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402045 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402045&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 146047652 405262036 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803754 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1cccnc1OC(C)C InChI=1S/C20H29N5O2/c1-7-25(12-11-24(6)20-22-15(4)13-16(5)23-20)19(26)17-9-8-10-21-18(17)27-14(2)3/h8-10,13-14H,7,11-12H2,1-6H3 PNCRQXVHBLHAKJ-UHFFFAOYSA-N 402046 N-(2-((4,6-dimethylpyrimidin-2- yl)(methyl)amino)ethyl)-N-ethyl-2- isopropoxynicotinamide::US10011595, B-5 Orexin receptor type 2 Homo sapiens 80.0 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402046 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402046&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416941 405262037 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803755 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1cccnc1OC(C)C InChI=1S/C20H29N5O2/c1-7-25(12-11-24(6)20-22-15(4)13-16(5)23-20)19(26)17-9-8-10-21-18(17)27-14(2)3/h8-10,13-14H,7,11-12H2,1-6H3 PNCRQXVHBLHAKJ-UHFFFAOYSA-N 402046 N-(2-((4,6-dimethylpyrimidin-2- yl)(methyl)amino)ethyl)-N-ethyl-2- isopropoxynicotinamide::US10011595, B-5 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402046 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402046&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416941 405262037 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803756 CCOc1ncccc1C(=O)N(CC)CCN(C)c1nc(C)cc(C)n1 InChI=1S/C19H27N5O2/c1-6-24(18(25)16-9-8-10-20-17(16)26-7-2)12-11-23(5)19-21-14(3)13-15(4)22-19/h8-10,13H,6-7,11-12H2,1-5H3 XDLMNJJRFWRSAN-UHFFFAOYSA-N 402047 N-(2-((4,6-dimethylpyrimidin-2- yl)(methyl)amino)ethyl)-2-ethoxy-N- ethylnicotinamide::US10011595, B-6 Orexin receptor type 2 Homo sapiens 68.1 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402047 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402047&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416827 405262038 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803757 CCOc1ncccc1C(=O)N(CC)CCN(C)c1nc(C)cc(C)n1 InChI=1S/C19H27N5O2/c1-6-24(18(25)16-9-8-10-20-17(16)26-7-2)12-11-23(5)19-21-14(3)13-15(4)22-19/h8-10,13H,6-7,11-12H2,1-5H3 XDLMNJJRFWRSAN-UHFFFAOYSA-N 402047 N-(2-((4,6-dimethylpyrimidin-2- yl)(methyl)amino)ethyl)-2-ethoxy-N- ethylnicotinamide::US10011595, B-6 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402047 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402047&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416827 405262038 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803758 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccccc1OC(F)(F)F InChI=1S/C19H23F3N4O2/c1-5-26(11-10-25(4)18-23-13(2)12-14(3)24-18)17(27)15-8-6-7-9-16(15)28-19(20,21)22/h6-9,12H,5,10-11H2,1-4H3 LZJJQGONRPKHMU-UHFFFAOYSA-N 402048 N-(2-((4,6-dimethylpyrimidin-2- yl)(methyl)amino)ethyl)-N-ethyl-2- (trifluoromethoxy)benzamide::US10011595, B-7 Orexin receptor type 2 Homo sapiens 9.40 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402048 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402048&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121427025 405262039 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803759 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccccc1OC(F)(F)F InChI=1S/C19H23F3N4O2/c1-5-26(11-10-25(4)18-23-13(2)12-14(3)24-18)17(27)15-8-6-7-9-16(15)28-19(20,21)22/h6-9,12H,5,10-11H2,1-4H3 LZJJQGONRPKHMU-UHFFFAOYSA-N 402048 N-(2-((4,6-dimethylpyrimidin-2- yl)(methyl)amino)ethyl)-N-ethyl-2- (trifluoromethoxy)benzamide::US10011595, B-7 Orexin/Hypocretin receptor type 1 Homo sapiens 1109 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402048 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402048&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121427025 405262039 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803760 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccccc1OC(F)F InChI=1S/C19H24F2N4O2/c1-5-25(11-10-24(4)19-22-13(2)12-14(3)23-19)17(26)15-8-6-7-9-16(15)27-18(20)21/h6-9,12,18H,5,10-11H2,1-4H3 ROVKCZCKOQHYAU-UHFFFAOYSA-N 402049 2-(difluoromethoxy)-N-(2-((4,6- dimethylpyrimidin-2- yl)(methyl)amino)ethyl)-N- ethylbenzamide::US10011595, B-8 Orexin receptor type 2 Homo sapiens 18.5 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402049 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402049&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416902 405262040 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803761 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccccc1OC(F)F InChI=1S/C19H24F2N4O2/c1-5-25(11-10-24(4)19-22-13(2)12-14(3)23-19)17(26)15-8-6-7-9-16(15)27-18(20)21/h6-9,12,18H,5,10-11H2,1-4H3 ROVKCZCKOQHYAU-UHFFFAOYSA-N 402049 2-(difluoromethoxy)-N-(2-((4,6- dimethylpyrimidin-2- yl)(methyl)amino)ethyl)-N- ethylbenzamide::US10011595, B-8 Orexin/Hypocretin receptor type 1 Homo sapiens 2175 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402049 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402049&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416902 405262040 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803762 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1cccnc1-c1ccccc1 InChI=1S/C23H27N5O/c1-5-28(15-14-27(4)23-25-17(2)16-18(3)26-23)22(29)20-12-9-13-24-21(20)19-10-7-6-8-11-19/h6-13,16H,5,14-15H2,1-4H3 SHGGFVGQUGZZDM-UHFFFAOYSA-N 402050 N-(2-((4,6-dimethylpyrimidin-2- yl)(methyl)amino)ethyl)-N-ethyl-2- phenylnicotinamide::US10011595, B-9 Orexin receptor type 2 Homo sapiens 26.4 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402050 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402050&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121427021 405262041 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803763 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1cccnc1-c1ccccc1 InChI=1S/C23H27N5O/c1-5-28(15-14-27(4)23-25-17(2)16-18(3)26-23)22(29)20-12-9-13-24-21(20)19-10-7-6-8-11-19/h6-13,16H,5,14-15H2,1-4H3 SHGGFVGQUGZZDM-UHFFFAOYSA-N 402050 N-(2-((4,6-dimethylpyrimidin-2- yl)(methyl)amino)ethyl)-N-ethyl-2- phenylnicotinamide::US10011595, B-9 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402050 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402050&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121427021 405262041 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803764 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1cccnc1OCC(F)F InChI=1S/C19H25F2N5O2/c1-5-26(10-9-25(4)19-23-13(2)11-14(3)24-19)18(27)15-7-6-8-22-17(15)28-12-16(20)21/h6-8,11,16H,5,9-10,12H2,1-4H3 ZAXQKFPMGTZSLN-UHFFFAOYSA-N 402052 2-(2,2-difluoroethoxy)-N-(2-((4,6- dimethylpyrimidin-2- yl)(methyl)amino)ethyl)-N- ethylnicotinamide::US10011595, B-10 Orexin receptor type 2 Homo sapiens 40.6 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402052 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402052&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121427020 405262043 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803765 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1cccnc1OCC(F)F InChI=1S/C19H25F2N5O2/c1-5-26(10-9-25(4)19-23-13(2)11-14(3)24-19)18(27)15-7-6-8-22-17(15)28-12-16(20)21/h6-8,11,16H,5,9-10,12H2,1-4H3 ZAXQKFPMGTZSLN-UHFFFAOYSA-N 402052 2-(2,2-difluoroethoxy)-N-(2-((4,6- dimethylpyrimidin-2- yl)(methyl)amino)ethyl)-N- ethylnicotinamide::US10011595, B-10 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402052 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402052&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121427020 405262043 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803766 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1cccnc1OCC(F)(F)F InChI=1S/C19H24F3N5O2/c1-5-27(10-9-26(4)18-24-13(2)11-14(3)25-18)17(28)15-7-6-8-23-16(15)29-12-19(20,21)22/h6-8,11H,5,9-10,12H2,1-4H3 AIKDJLKBRWWSOF-UHFFFAOYSA-N 402053 N-(2-((4,6-dimethylpyrimidin-2- yl)(methyl)amino)ethyl)-N-ethyl-2- (2,2,2-trifluoroethoxy)nicotinamide::US10011595, B-11 Orexin receptor type 2 Homo sapiens 19.8 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402053 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402053&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416837 405262044 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803767 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1cccnc1OCC(F)(F)F InChI=1S/C19H24F3N5O2/c1-5-27(10-9-26(4)18-24-13(2)11-14(3)25-18)17(28)15-7-6-8-23-16(15)29-12-19(20,21)22/h6-8,11H,5,9-10,12H2,1-4H3 AIKDJLKBRWWSOF-UHFFFAOYSA-N 402053 N-(2-((4,6-dimethylpyrimidin-2- yl)(methyl)amino)ethyl)-N-ethyl-2- (2,2,2-trifluoroethoxy)nicotinamide::US10011595, B-11 Orexin/Hypocretin receptor type 1 Homo sapiens 6093 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402053 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402053&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416837 405262044 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803768 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccc(F)cc1-n1nccn1 InChI=1S/C20H24FN7O/c1-5-27(11-10-26(4)20-24-14(2)12-15(3)25-20)19(29)17-7-6-16(21)13-18(17)28-22-8-9-23-28/h6-9,12-13H,5,10-11H2,1-4H3 JVEQWXPKUYMQAY-UHFFFAOYSA-N 402054 N-(2-((4,6-dimethylpyrimidin-2- yl)(methyl)amino)ethyl)-N-ethyl-4- fluoro-2-(2H-1,2,3-triazol-2- yl)benzamide::US10011595, B-12 Orexin receptor type 2 Homo sapiens 12.6 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402054 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402054&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121427019 405262045 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803769 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccc(F)cc1-n1nccn1 InChI=1S/C20H24FN7O/c1-5-27(11-10-26(4)20-24-14(2)12-15(3)25-20)19(29)17-7-6-16(21)13-18(17)28-22-8-9-23-28/h6-9,12-13H,5,10-11H2,1-4H3 JVEQWXPKUYMQAY-UHFFFAOYSA-N 402054 N-(2-((4,6-dimethylpyrimidin-2- yl)(methyl)amino)ethyl)-N-ethyl-4- fluoro-2-(2H-1,2,3-triazol-2- yl)benzamide::US10011595, B-12 Orexin/Hypocretin receptor type 1 Homo sapiens 2827 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402054 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402054&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121427019 405262045 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803770 CCOc1ccccc1C(=O)N(CC)CCN(C)c1nc(C)cc(C)n1 InChI=1S/C20H28N4O2/c1-6-24(19(25)17-10-8-9-11-18(17)26-7-2)13-12-23(5)20-21-15(3)14-16(4)22-20/h8-11,14H,6-7,12-13H2,1-5H3 JCBRAODYZJUEIE-UHFFFAOYSA-N 402055 N-(2-((4,6-dimethylpyrimidin-2- yl)(methyl)amino)ethyl)-2-ethoxy-N- ethylbenzamide::US10011595, B-13 Orexin receptor type 2 Homo sapiens 16.0 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402055 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402055&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416940 405262046 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803771 CCOc1ccccc1C(=O)N(CC)CCN(C)c1nc(C)cc(C)n1 InChI=1S/C20H28N4O2/c1-6-24(19(25)17-10-8-9-11-18(17)26-7-2)13-12-23(5)20-21-15(3)14-16(4)22-20/h8-11,14H,6-7,12-13H2,1-5H3 JCBRAODYZJUEIE-UHFFFAOYSA-N 402055 N-(2-((4,6-dimethylpyrimidin-2- yl)(methyl)amino)ethyl)-2-ethoxy-N- ethylbenzamide::US10011595, B-13 Orexin/Hypocretin receptor type 1 Homo sapiens 2006 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402055 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402055&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416940 405262046 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803772 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccccc1-n1cccn1 InChI=1S/C21H26N6O/c1-5-26(14-13-25(4)21-23-16(2)15-17(3)24-21)20(28)18-9-6-7-10-19(18)27-12-8-11-22-27/h6-12,15H,5,13-14H2,1-4H3 YQAKEEXTPKVOQK-UHFFFAOYSA-N 402056 N-(2-((4,6-dimethylpyrimidin-2- yl)(methyl)amino)ethyl)-N-ethyl-2- (1H-pyrazol-1-yl)benzamide::US10011595, B-14 Orexin receptor type 2 Homo sapiens 13.9 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402056 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402056&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416920 405262047 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803773 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccccc1-n1cccn1 InChI=1S/C21H26N6O/c1-5-26(14-13-25(4)21-23-16(2)15-17(3)24-21)20(28)18-9-6-7-10-19(18)27-12-8-11-22-27/h6-12,15H,5,13-14H2,1-4H3 YQAKEEXTPKVOQK-UHFFFAOYSA-N 402056 N-(2-((4,6-dimethylpyrimidin-2- yl)(methyl)amino)ethyl)-N-ethyl-2- (1H-pyrazol-1-yl)benzamide::US10011595, B-14 Orexin/Hypocretin receptor type 1 Homo sapiens 2600 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402056 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402056&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416920 405262047 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803774 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1nccnc1-n1nccn1 InChI=1S/C18H23N9O/c1-5-26(11-10-25(4)18-23-13(2)12-14(3)24-18)17(28)15-16(20-7-6-19-15)27-21-8-9-22-27/h6-9,12H,5,10-11H2,1-4H3 MWRLOGYGYHCYEB-UHFFFAOYSA-N 402057 N-(2-((4,6-dimethylpyrimidin-2- yl)(methyl)amino)ethyl)-N-ethyl-3- (2H-1,2,3-triazol-2-yl)pyrazine-2- carboxamide::US10011595, B-15 Orexin receptor type 2 Homo sapiens 1271 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402057 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402057&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416948 405262048 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803775 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1nccnc1-n1nccn1 InChI=1S/C18H23N9O/c1-5-26(11-10-25(4)18-23-13(2)12-14(3)24-18)17(28)15-16(20-7-6-19-15)27-21-8-9-22-27/h6-9,12H,5,10-11H2,1-4H3 MWRLOGYGYHCYEB-UHFFFAOYSA-N 402057 N-(2-((4,6-dimethylpyrimidin-2- yl)(methyl)amino)ethyl)-N-ethyl-3- (2H-1,2,3-triazol-2-yl)pyrazine-2- carboxamide::US10011595, B-15 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402057 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402057&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416948 405262048 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803776 CCCc1ccccc1C(=O)N(CC)CCN(C)c1nc(C)cc(C)n1 InChI=1S/C21H30N4O/c1-6-10-18-11-8-9-12-19(18)20(26)25(7-2)14-13-24(5)21-22-16(3)15-17(4)23-21/h8-9,11-12,15H,6-7,10,13-14H2,1-5H3 AGDLVWYRRUZCJS-UHFFFAOYSA-N 402058 N-{2-[(4,6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-2- propylbenzamide::US10011595, B-16 Orexin receptor type 2 Homo sapiens 19.9 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402058 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402058&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416900 405262049 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803777 CCCc1ccccc1C(=O)N(CC)CCN(C)c1nc(C)cc(C)n1 InChI=1S/C21H30N4O/c1-6-10-18-11-8-9-12-19(18)20(26)25(7-2)14-13-24(5)21-22-16(3)15-17(4)23-21/h8-9,11-12,15H,6-7,10,13-14H2,1-5H3 AGDLVWYRRUZCJS-UHFFFAOYSA-N 402058 N-{2-[(4,6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-2- propylbenzamide::US10011595, B-16 Orexin/Hypocretin receptor type 1 Homo sapiens 1650 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402058 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402058&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416900 405262049 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803778 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccccc1OCC(F)(F)F InChI=1S/C20H25F3N4O2/c1-5-27(11-10-26(4)19-24-14(2)12-15(3)25-19)18(28)16-8-6-7-9-17(16)29-13-20(21,22)23/h6-9,12H,5,10-11,13H2,1-4H3 XQCHKDHNDRGQAH-UHFFFAOYSA-N 402059 N-{2-[(4, 6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-2- (2,2,2-trifluoroethoxy)-benzamide::US10011595, B-17 Orexin receptor type 2 Homo sapiens 11.2 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402059 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402059&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 132209822 405262050 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803779 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccccc1OCC(F)(F)F InChI=1S/C20H25F3N4O2/c1-5-27(11-10-26(4)19-24-14(2)12-15(3)25-19)18(28)16-8-6-7-9-17(16)29-13-20(21,22)23/h6-9,12H,5,10-11,13H2,1-4H3 XQCHKDHNDRGQAH-UHFFFAOYSA-N 402059 N-{2-[(4, 6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-2- (2,2,2-trifluoroethoxy)-benzamide::US10011595, B-17 Orexin/Hypocretin receptor type 1 Homo sapiens 2031 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402059 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402059&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 132209822 405262050 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803780 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccccc1CC(F)(F)F InChI=1S/C20H25F3N4O/c1-5-27(11-10-26(4)19-24-14(2)12-15(3)25-19)18(28)17-9-7-6-8-16(17)13-20(21,22)23/h6-9,12H,5,10-11,13H2,1-4H3 FWSDYYXATTZVDT-UHFFFAOYSA-N 402060 N-{2-[(4,6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-2- (2,2,2-trifluoroethyl)benzamide::US10011595, B-18 Orexin receptor type 2 Homo sapiens 36.2 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402060 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402060&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416919 405262051 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803781 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccccc1CC(F)(F)F InChI=1S/C20H25F3N4O/c1-5-27(11-10-26(4)19-24-14(2)12-15(3)25-19)18(28)17-9-7-6-8-16(17)13-20(21,22)23/h6-9,12H,5,10-11,13H2,1-4H3 FWSDYYXATTZVDT-UHFFFAOYSA-N 402060 N-{2-[(4,6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-2- (2,2,2-trifluoroethyl)benzamide::US10011595, B-18 Orexin/Hypocretin receptor type 1 Homo sapiens 3637 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402060 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402060&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416919 405262051 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803782 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccc(OC)nc1C1CC1 InChI=1S/C21H29N5O2/c1-6-26(12-11-25(4)21-22-14(2)13-15(3)23-21)20(27)17-9-10-18(28-5)24-19(17)16-7-8-16/h9-10,13,16H,6-8,11-12H2,1-5H3 VLLVBCCTOIMVGZ-UHFFFAOYSA-N 402061 2-cyclopropyl-N-{2-[(4,6- dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-6- methoxypyridine-3-carboxamide::US10011595, B-19 Orexin receptor type 2 Homo sapiens 32.1 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402061 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402061&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 132209815 405262052 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803783 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccc(OC)nc1C1CC1 InChI=1S/C21H29N5O2/c1-6-26(12-11-25(4)21-22-14(2)13-15(3)23-21)20(27)17-9-10-18(28-5)24-19(17)16-7-8-16/h9-10,13,16H,6-8,11-12H2,1-5H3 VLLVBCCTOIMVGZ-UHFFFAOYSA-N 402061 2-cyclopropyl-N-{2-[(4,6- dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-6- methoxypyridine-3-carboxamide::US10011595, B-19 Orexin/Hypocretin receptor type 1 Homo sapiens 9682 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402061 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402061&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 132209815 405262052 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803784 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccccc1OCC(F)F InChI=1S/C20H26F2N4O2/c1-5-26(11-10-25(4)20-23-14(2)12-15(3)24-20)19(27)16-8-6-7-9-17(16)28-13-18(21)22/h6-9,12,18H,5,10-11,13H2,1-4H3 VERXBTJKXAFEKY-UHFFFAOYSA-N 402062 2-(2,2-difluoroethoxy)-N-{2-[(4,6- dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N- ethylbenzamide::US10011595, B-20 Orexin receptor type 2 Homo sapiens 9.20 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402062 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402062&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416928 405262053 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803785 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccccc1OCC(F)F InChI=1S/C20H26F2N4O2/c1-5-26(11-10-25(4)20-23-14(2)12-15(3)24-20)19(27)16-8-6-7-9-17(16)28-13-18(21)22/h6-9,12,18H,5,10-11,13H2,1-4H3 VERXBTJKXAFEKY-UHFFFAOYSA-N 402062 2-(2,2-difluoroethoxy)-N-{2-[(4,6- dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N- ethylbenzamide::US10011595, B-20 Orexin/Hypocretin receptor type 1 Homo sapiens 1559 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402062 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402062&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416928 405262053 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803786 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1cccnc1CC(F)(F)F InChI=1S/C19H24F3N5O/c1-5-27(10-9-26(4)18-24-13(2)11-14(3)25-18)17(28)15-7-6-8-23-16(15)12-19(20,21)22/h6-8,11H,5,9-10,12H2,1-4H3 HXAPYZHGRMNUQS-UHFFFAOYSA-N 402063 N-{2-[(4,6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-2- (2,2,2-trifluoroethyl)pyridine-3- carboxamide::US10011595, B-21 Orexin receptor type 2 Homo sapiens 424 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402063 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402063&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416897 405262054 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803787 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1cccnc1CC(F)(F)F InChI=1S/C19H24F3N5O/c1-5-27(10-9-26(4)18-24-13(2)11-14(3)25-18)17(28)15-7-6-8-23-16(15)12-19(20,21)22/h6-8,11H,5,9-10,12H2,1-4H3 HXAPYZHGRMNUQS-UHFFFAOYSA-N 402063 N-{2-[(4,6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-2- (2,2,2-trifluoroethyl)pyridine-3- carboxamide::US10011595, B-21 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402063 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402063&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416897 405262054 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803788 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ncccc1-n1nccn1 InChI=1S/C19H24N8O/c1-5-26(12-11-25(4)19-23-14(2)13-15(3)24-19)18(28)17-16(7-6-8-20-17)27-21-9-10-22-27/h6-10,13H,5,11-12H2,1-4H3 RJOJHBJNLKRONY-UHFFFAOYSA-N 402064 N-{2-[(4,6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-3- (2H-1,2,3-triazol-2-yl)pyridine-2- carboxamide::US10011595, B-22 Orexin receptor type 2 Homo sapiens 32.4 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402064 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402064&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416968 405262055 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803789 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ncccc1-n1nccn1 InChI=1S/C19H24N8O/c1-5-26(12-11-25(4)19-23-14(2)13-15(3)24-19)18(28)17-16(7-6-8-20-17)27-21-9-10-22-27/h6-10,13H,5,11-12H2,1-4H3 RJOJHBJNLKRONY-UHFFFAOYSA-N 402064 N-{2-[(4,6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-3- (2H-1,2,3-triazol-2-yl)pyridine-2- carboxamide::US10011595, B-22 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402064 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402064&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416968 405262055 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803790 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccccc1CC(F)F InChI=1S/C20H26F2N4O/c1-5-26(11-10-25(4)20-23-14(2)12-15(3)24-20)19(27)17-9-7-6-8-16(17)13-18(21)22/h6-9,12,18H,5,10-11,13H2,1-4H3 OQLOKSXQUPMLOG-UHFFFAOYSA-N 402065 2-(2,2-difluoroethyl)-N-{2-[(4,6- dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N- ethylbenzamide::US10011595, B-23 Orexin receptor type 2 Homo sapiens 94.9 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402065 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402065&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 132209829 405262056 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803791 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccccc1CC(F)F InChI=1S/C20H26F2N4O/c1-5-26(11-10-25(4)20-23-14(2)12-15(3)24-20)19(27)17-9-7-6-8-16(17)13-18(21)22/h6-9,12,18H,5,10-11,13H2,1-4H3 OQLOKSXQUPMLOG-UHFFFAOYSA-N 402065 2-(2,2-difluoroethyl)-N-{2-[(4,6- dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N- ethylbenzamide::US10011595, B-23 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402065 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402065&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 132209829 405262056 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803792 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1cccnc1-n1cccn1 InChI=1S/C20H25N7O/c1-5-26(13-12-25(4)20-23-15(2)14-16(3)24-20)19(28)17-8-6-9-21-18(17)27-11-7-10-22-27/h6-11,14H,5,12-13H2,1-4H3 UBMCISCOTUHCMN-UHFFFAOYSA-N 402066 N-{2-[(4,6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-2- (1H-pyrazol-1-yl)pyridine-3- carboxamide::US10011595, B-24 Orexin receptor type 2 Homo sapiens 12.8 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402066 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402066&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 132209835 405262057 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803793 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1cccnc1-n1cccn1 InChI=1S/C20H25N7O/c1-5-26(13-12-25(4)20-23-15(2)14-16(3)24-20)19(28)17-8-6-9-21-18(17)27-11-7-10-22-27/h6-11,14H,5,12-13H2,1-4H3 UBMCISCOTUHCMN-UHFFFAOYSA-N 402066 N-{2-[(4,6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-2- (1H-pyrazol-1-yl)pyridine-3- carboxamide::US10011595, B-24 Orexin/Hypocretin receptor type 1 Homo sapiens 5081 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402066 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402066&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 132209835 405262057 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803794 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1nccnc1N1CCCC1 InChI=1S/C20H29N7O/c1-5-26(13-12-25(4)20-23-15(2)14-16(3)24-20)19(28)17-18(22-9-8-21-17)27-10-6-7-11-27/h8-9,14H,5-7,10-13H2,1-4H3 PUWBONXQMIDQBH-UHFFFAOYSA-N 402067 N-{2-[(4,6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-3- pyrrolidin-1-ylpyrazine-2-carboxamide::US10011595, B-25 Orexin receptor type 2 Homo sapiens 324 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402067 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402067&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121427030 405262058 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803795 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1nccnc1N1CCCC1 InChI=1S/C20H29N7O/c1-5-26(13-12-25(4)20-23-15(2)14-16(3)24-20)19(28)17-18(22-9-8-21-17)27-10-6-7-11-27/h8-9,14H,5-7,10-13H2,1-4H3 PUWBONXQMIDQBH-UHFFFAOYSA-N 402067 N-{2-[(4,6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-3- pyrrolidin-1-ylpyrazine-2-carboxamide::US10011595, B-25 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402067 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402067&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121427030 405262058 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803796 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccccc1C1CCC1 InChI=1S/C22H30N4O/c1-5-26(14-13-25(4)22-23-16(2)15-17(3)24-22)21(27)20-12-7-6-11-19(20)18-9-8-10-18/h6-7,11-12,15,18H,5,8-10,13-14H2,1-4H3 NOLGTXNFZRHOLY-UHFFFAOYSA-N 402068 2-cyclobutyl-N-{2-[(4,6- dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N- ethylbenzamide::US10011595, B-26 Orexin receptor type 2 Homo sapiens 20.4 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402068 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402068&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416817 405262059 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803797 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccccc1C1CCC1 InChI=1S/C22H30N4O/c1-5-26(14-13-25(4)22-23-16(2)15-17(3)24-22)21(27)20-12-7-6-11-19(20)18-9-8-10-18/h6-7,11-12,15,18H,5,8-10,13-14H2,1-4H3 NOLGTXNFZRHOLY-UHFFFAOYSA-N 402068 2-cyclobutyl-N-{2-[(4,6- dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N- ethylbenzamide::US10011595, B-26 Orexin/Hypocretin receptor type 1 Homo sapiens 1183 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402068 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402068&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416817 405262059 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803798 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ncccc1-c1ccccc1 InChI=1S/C23H27N5O/c1-5-28(15-14-27(4)23-25-17(2)16-18(3)26-23)22(29)21-20(12-9-13-24-21)19-10-7-6-8-11-19/h6-13,16H,5,14-15H2,1-4H3 NHAFCQONVFABDQ-UHFFFAOYSA-N 402069 N-{2-[(4,6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-3- phenylpyridine-2-carboxamide::US10011595, B-27 Orexin receptor type 2 Homo sapiens 12.5 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402069 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402069&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121427031 405262060 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803799 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ncccc1-c1ccccc1 InChI=1S/C23H27N5O/c1-5-28(15-14-27(4)23-25-17(2)16-18(3)26-23)22(29)21-20(12-9-13-24-21)19-10-7-6-8-11-19/h6-13,16H,5,14-15H2,1-4H3 NHAFCQONVFABDQ-UHFFFAOYSA-N 402069 N-{2-[(4,6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-3- phenylpyridine-2-carboxamide::US10011595, B-27 Orexin/Hypocretin receptor type 1 Homo sapiens 759 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402069 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402069&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121427031 405262060 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803800 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1nccnc1-n1cccn1 InChI=1S/C19H24N8O/c1-5-26(12-11-25(4)19-23-14(2)13-15(3)24-19)18(28)16-17(21-9-8-20-16)27-10-6-7-22-27/h6-10,13H,5,11-12H2,1-4H3 MBQGJUMSGSVXIS-UHFFFAOYSA-N 402070 N-{2-[(4,6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-3- (1H-pyrazol-1-yl)pyrazine-2- carboxamide::US10011595, B-28 Orexin receptor type 2 Homo sapiens 18.7 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402070 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402070&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416912 405262061 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803801 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1nccnc1-n1cccn1 InChI=1S/C19H24N8O/c1-5-26(12-11-25(4)19-23-14(2)13-15(3)24-19)18(28)16-17(21-9-8-20-16)27-10-6-7-22-27/h6-10,13H,5,11-12H2,1-4H3 MBQGJUMSGSVXIS-UHFFFAOYSA-N 402070 N-{2-[(4,6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-3- (1H-pyrazol-1-yl)pyrazine-2- carboxamide::US10011595, B-28 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402070 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402070&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416912 405262061 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803802 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccccc1C1CC1(F)F InChI=1S/C21H26F2N4O/c1-5-27(11-10-26(4)20-24-14(2)12-15(3)25-20)19(28)17-9-7-6-8-16(17)18-13-21(18,22)23/h6-9,12,18H,5,10-11,13H2,1-4H3 MZKQCHLHPUUJJL-UHFFFAOYSA-N 402071 2-(2,2-difluorocyclopropyl)-N-{2- [(4,6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N- ethylbenzamide::US10011595, B-29 Orexin receptor type 2 Homo sapiens 18.9 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402071 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402071&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416855 405262062 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803803 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccccc1C1CC1(F)F InChI=1S/C21H26F2N4O/c1-5-27(11-10-26(4)20-24-14(2)12-15(3)25-20)19(28)17-9-7-6-8-16(17)18-13-21(18,22)23/h6-9,12,18H,5,10-11,13H2,1-4H3 MZKQCHLHPUUJJL-UHFFFAOYSA-N 402071 2-(2,2-difluorocyclopropyl)-N-{2- [(4,6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N- ethylbenzamide::US10011595, B-29 Orexin/Hypocretin receptor type 1 Homo sapiens 3013 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402071 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402071&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416855 405262062 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803804 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccccc1N1CCCC1 InChI=1S/C22H31N5O/c1-5-26(15-14-25(4)22-23-17(2)16-18(3)24-22)21(28)19-10-6-7-11-20(19)27-12-8-9-13-27/h6-7,10-11,16H,5,8-9,12-15H2,1-4H3 PPLHYKMQZGWEHE-UHFFFAOYSA-N 402072 N-{2-[(4,6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-2- pyrrolidin-1-ylbenzamide::US10011595, B-30 Orexin receptor type 2 Homo sapiens 18.5 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402072 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402072&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121426964 405262063 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803805 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccccc1N1CCCC1 InChI=1S/C22H31N5O/c1-5-26(15-14-25(4)22-23-17(2)16-18(3)24-22)21(28)19-10-6-7-11-20(19)27-12-8-9-13-27/h6-7,10-11,16H,5,8-9,12-15H2,1-4H3 PPLHYKMQZGWEHE-UHFFFAOYSA-N 402072 N-{2-[(4,6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-2- pyrrolidin-1-ylbenzamide::US10011595, B-30 Orexin/Hypocretin receptor type 1 Homo sapiens 790 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402072 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402072&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121426964 405262063 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803806 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccccc1-n1ncnn1 InChI=1S/C19H24N8O/c1-5-26(11-10-25(4)19-22-14(2)12-15(3)23-19)18(28)16-8-6-7-9-17(16)27-21-13-20-24-27/h6-9,12-13H,5,10-11H2,1-4H3 SSBPIQVLUCHSSH-UHFFFAOYSA-N 402073 N-{2-[(4,6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-2- (2H-tetrazol-2-yl)benzamide::US10011595, B-31 Orexin receptor type 2 Homo sapiens 8.80 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402073 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402073&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416954 405262064 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803807 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccccc1-n1ncnn1 InChI=1S/C19H24N8O/c1-5-26(11-10-25(4)19-22-14(2)12-15(3)23-19)18(28)16-8-6-7-9-17(16)27-21-13-20-24-27/h6-9,12-13H,5,10-11H2,1-4H3 SSBPIQVLUCHSSH-UHFFFAOYSA-N 402073 N-{2-[(4,6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-2- (2H-tetrazol-2-yl)benzamide::US10011595, B-31 Orexin/Hypocretin receptor type 1 Homo sapiens 2564 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402073 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402073&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416954 405262064 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803808 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccccc1-c1ncccn1 InChI=1S/C22H26N6O/c1-5-28(14-13-27(4)22-25-16(2)15-17(3)26-22)21(29)19-10-7-6-9-18(19)20-23-11-8-12-24-20/h6-12,15H,5,13-14H2,1-4H3 HUHRCAKELHAVDP-UHFFFAOYSA-N 402074 N-{2-[(4,6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-2- pyrimidin-2-ylbenzamide::US10011595, B-32 Orexin receptor type 2 Homo sapiens 19.5 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402074 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402074&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121426966 405262065 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803809 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1ccccc1-c1ncccn1 InChI=1S/C22H26N6O/c1-5-28(14-13-27(4)22-25-16(2)15-17(3)26-22)21(29)19-10-7-6-9-18(19)20-23-11-8-12-24-20/h6-12,15H,5,13-14H2,1-4H3 HUHRCAKELHAVDP-UHFFFAOYSA-N 402074 N-{2-[(4,6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-2- pyrimidin-2-ylbenzamide::US10011595, B-32 Orexin/Hypocretin receptor type 1 Homo sapiens 985 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402074 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402074&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121426966 405262065 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803810 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1nccnc1-c1ccccn1 InChI=1S/C21H25N7O/c1-5-28(13-12-27(4)21-25-15(2)14-16(3)26-21)20(29)19-18(23-10-11-24-19)17-8-6-7-9-22-17/h6-11,14H,5,12-13H2,1-4H3 BZUHICFLESKFHL-UHFFFAOYSA-N 402075 N-{2-[(4,6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-3- pyridin-2-ylpyrazine-2-carboxamide::US10011595, B-33 Orexin receptor type 2 Homo sapiens 23.0 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402075 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402075&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121426968 405262066 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803811 CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1nccnc1-c1ccccn1 InChI=1S/C21H25N7O/c1-5-28(13-12-27(4)21-25-15(2)14-16(3)26-21)20(29)19-18(23-10-11-24-19)17-8-6-7-9-22-17/h6-11,14H,5,12-13H2,1-4H3 BZUHICFLESKFHL-UHFFFAOYSA-N 402075 N-{2-[(4,6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-3- pyridin-2-ylpyrazine-2-carboxamide::US10011595, B-33 Orexin/Hypocretin receptor type 1 Homo sapiens 7200 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402075 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402075&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121426968 405262066 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803812 CCN(CCN(CC)c1nc(C)cc(C)n1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C21H27N7O/c1-5-26(13-14-27(6-2)21-24-16(3)15-17(4)25-21)20(29)18-9-7-8-10-19(18)28-22-11-12-23-28/h7-12,15H,5-6,13-14H2,1-4H3 VACXGDAMAVWGEM-UHFFFAOYSA-N 402076 N-(2-((4,6-dimethylpyrimidin-2-yl)(ethyl)amino)ethyl)-N-ethyl-2-(2H-H-1,2,3-triazol-2-yl)benzamide::US10011595, C-1 Orexin receptor type 2 Homo sapiens 36.6 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402076 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402076&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416909 405262067 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803813 CCN(CCN(CC)c1nc(C)cc(C)n1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C21H27N7O/c1-5-26(13-14-27(6-2)21-24-16(3)15-17(4)25-21)20(29)18-9-7-8-10-19(18)28-22-11-12-23-28/h7-12,15H,5-6,13-14H2,1-4H3 VACXGDAMAVWGEM-UHFFFAOYSA-N 402076 N-(2-((4,6-dimethylpyrimidin-2-yl)(ethyl)amino)ethyl)-N-ethyl-2-(2H-H-1,2,3-triazol-2-yl)benzamide::US10011595, C-1 Orexin/Hypocretin receptor type 1 Homo sapiens 3173 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402076 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402076&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416909 405262067 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803814 CCN(CCN(C(C)C)c1nc(C)cc(C)n1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H29N7O/c1-6-27(13-14-28(16(2)3)22-25-17(4)15-18(5)26-22)21(30)19-9-7-8-10-20(19)29-23-11-12-24-29/h7-12,15-16H,6,13-14H2,1-5H3 BWNJKKHMXQNMMR-UHFFFAOYSA-N 402077 N-(2-((4,6-dimethylpyrimidin-2- yl)(isopropyl)amino)ethyl)-N- ethyl-2-(2H-1,2,3-triazol-2- yl)benzamide::US10011595, C-3 Orexin receptor type 2 Homo sapiens 1457 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402077 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402077&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416868 405262068 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803815 CCN(CCN(C(C)C)c1nc(C)cc(C)n1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H29N7O/c1-6-27(13-14-28(16(2)3)22-25-17(4)15-18(5)26-22)21(30)19-9-7-8-10-20(19)29-23-11-12-24-29/h7-12,15-16H,6,13-14H2,1-5H3 BWNJKKHMXQNMMR-UHFFFAOYSA-N 402077 N-(2-((4,6-dimethylpyrimidin-2- yl)(isopropyl)amino)ethyl)-N- ethyl-2-(2H-1,2,3-triazol-2- yl)benzamide::US10011595, C-3 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402077 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402077&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416868 405262068 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803816 CCN(CCN(CC(F)F)c1nc(C)cc(C)n1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C21H25F2N7O/c1-4-28(20(31)17-7-5-6-8-18(17)30-24-9-10-25-30)11-12-29(14-19(22)23)21-26-15(2)13-16(3)27-21/h5-10,13,19H,4,11-12,14H2,1-3H3 KHIBBWWVGAIPMT-UHFFFAOYSA-N 402078 N-(2-((2,2-difluoroethyl)(4,6-dimethylpyrimidin-2-yl)amino)ethyl)-N-ethyl-2-(2H-1,2,3-triazol-2-yl)benzamide::US10011595, D-1 Orexin receptor type 2 Homo sapiens 56.1 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402078 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402078&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416886 405262069 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803817 CCN(CCN(CC(F)F)c1nc(C)cc(C)n1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C21H25F2N7O/c1-4-28(20(31)17-7-5-6-8-18(17)30-24-9-10-25-30)11-12-29(14-19(22)23)21-26-15(2)13-16(3)27-21/h5-10,13,19H,4,11-12,14H2,1-3H3 KHIBBWWVGAIPMT-UHFFFAOYSA-N 402078 N-(2-((2,2-difluoroethyl)(4,6-dimethylpyrimidin-2-yl)amino)ethyl)-N-ethyl-2-(2H-1,2,3-triazol-2-yl)benzamide::US10011595, D-1 Orexin/Hypocretin receptor type 1 Homo sapiens 3295 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402078 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402078&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416886 405262069 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803818 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-n1nccn1 InChI=1S/C20H21N7O/c1-3-26(13-12-25(2)19-14-16(15-21)8-9-22-19)20(28)17-6-4-5-7-18(17)27-23-10-11-24-27/h4-11,14H,3,12-13H2,1-2H3 SVMUFUOYEYJDQC-UHFFFAOYSA-N 402079 N-(2-((4-cyanopyridin-2-yl)(methyl)amino)ethyl)-N-ethyl-2-(2H-1,2,3-triazol-2-yl)benzamide::US10011595, E-1 Orexin receptor type 2 Homo sapiens 14.5 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402079 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402079&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416927 405262070 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803819 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-n1nccn1 InChI=1S/C20H21N7O/c1-3-26(13-12-25(2)19-14-16(15-21)8-9-22-19)20(28)17-6-4-5-7-18(17)27-23-10-11-24-27/h4-11,14H,3,12-13H2,1-2H3 SVMUFUOYEYJDQC-UHFFFAOYSA-N 402079 N-(2-((4-cyanopyridin-2-yl)(methyl)amino)ethyl)-N-ethyl-2-(2H-1,2,3-triazol-2-yl)benzamide::US10011595, E-1 Orexin/Hypocretin receptor type 1 Homo sapiens 7631 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402079 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402079&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416927 405262070 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803820 CCN(CCN(C)c1nccc(C#N)c1C)C(=O)c1ccccc1-n1nccn1 InChI=1S/C21H23N7O/c1-4-27(14-13-26(3)20-16(2)17(15-22)9-10-23-20)21(29)18-7-5-6-8-19(18)28-24-11-12-25-28/h5-12H,4,13-14H2,1-3H3 FKNAGPPGNKZRBQ-UHFFFAOYSA-N 402080 N-(2-((4-cyano-3- methylpyridin-2- yl)(methyl)amino)ethyl)-N- ethyl-2-(2H-1,2,3-triazol-2- yl)benzamide::US10011595, E-7 Orexin receptor type 2 Homo sapiens 198 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402080 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402080&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416890 405262071 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803821 CCN(CCN(C)c1nccc(C#N)c1C)C(=O)c1ccccc1-n1nccn1 InChI=1S/C21H23N7O/c1-4-27(14-13-26(3)20-16(2)17(15-22)9-10-23-20)21(29)18-7-5-6-8-19(18)28-24-11-12-25-28/h5-12H,4,13-14H2,1-3H3 FKNAGPPGNKZRBQ-UHFFFAOYSA-N 402080 N-(2-((4-cyano-3- methylpyridin-2- yl)(methyl)amino)ethyl)-N- ethyl-2-(2H-1,2,3-triazol-2- yl)benzamide::US10011595, E-7 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402080 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402080&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416890 405262071 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803822 CCN(CCN(C)c1nccc(C#N)c1Cl)C(=O)c1ccccc1-n1nccn1 InChI=1S/C20H20ClN7O/c1-3-27(13-12-26(2)19-18(21)15(14-22)8-9-23-19)20(29)16-6-4-5-7-17(16)28-24-10-11-25-28/h4-11H,3,12-13H2,1-2H3 QOOBANMTKWHRSE-UHFFFAOYSA-N 402081 N-{2-[(3-chloro-4- cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(2H-1,2,3-triazol-2- yl)benzamide::US10011595, E-8 Orexin receptor type 2 Homo sapiens 110 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402081 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402081&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416915 405262072 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803823 CCN(CCN(C)c1nccc(C#N)c1Cl)C(=O)c1ccccc1-n1nccn1 InChI=1S/C20H20ClN7O/c1-3-27(13-12-26(2)19-18(21)15(14-22)8-9-23-19)20(29)16-6-4-5-7-17(16)28-24-10-11-25-28/h4-11H,3,12-13H2,1-2H3 QOOBANMTKWHRSE-UHFFFAOYSA-N 402081 N-{2-[(3-chloro-4- cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(2H-1,2,3-triazol-2- yl)benzamide::US10011595, E-8 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402081 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402081&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416915 405262072 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803824 CCN(CCN(C)c1nc(OC)cc(OC)n1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C20H25N7O3/c1-5-26(13-12-25(2)20-23-17(29-3)14-18(24-20)30-4)19(28)15-8-6-7-9-16(15)27-21-10-11-22-27/h6-11,14H,5,12-13H2,1-4H3 GQLHMJGTXDXXRM-UHFFFAOYSA-N 402082 N-{2-[(4,6- dimethoxypyrimidin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(2H-1,2,3-triazol-2- yl)benzamide::US10011595, E-9 Orexin receptor type 2 Homo sapiens 341 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402082 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402082&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416974 405262073 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803825 CCN(CCN(C)c1nc(OC)cc(OC)n1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C20H25N7O3/c1-5-26(13-12-25(2)20-23-17(29-3)14-18(24-20)30-4)19(28)15-8-6-7-9-16(15)27-21-10-11-22-27/h6-11,14H,5,12-13H2,1-4H3 GQLHMJGTXDXXRM-UHFFFAOYSA-N 402082 N-{2-[(4,6- dimethoxypyrimidin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(2H-1,2,3-triazol-2- yl)benzamide::US10011595, E-9 Orexin/Hypocretin receptor type 1 Homo sapiens 8214 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402082 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402082&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416974 405262073 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803826 CCN(CCN(C)c1nccc(n1)C#N)C(=O)c1ccccc1-n1nccn1 InChI=1S/C19H20N8O/c1-3-26(13-12-25(2)19-21-9-8-15(14-20)24-19)18(28)16-6-4-5-7-17(16)27-22-10-11-23-27/h4-11H,3,12-13H2,1-2H3 KXPCQEUMAYDWRJ-UHFFFAOYSA-N 402083 N-{2-[(4-cyanopyrimidin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(2H-1,2,3-triazol-2- yl)benzamide::US10011595, E-10 Orexin receptor type 2 Homo sapiens 244 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402083 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402083&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416946 405262074 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803827 CCN(CCN(C)c1nccc(n1)C#N)C(=O)c1ccccc1-n1nccn1 InChI=1S/C19H20N8O/c1-3-26(13-12-25(2)19-21-9-8-15(14-20)24-19)18(28)16-6-4-5-7-17(16)27-22-10-11-23-27/h4-11H,3,12-13H2,1-2H3 KXPCQEUMAYDWRJ-UHFFFAOYSA-N 402083 N-{2-[(4-cyanopyrimidin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(2H-1,2,3-triazol-2- yl)benzamide::US10011595, E-10 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402083 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402083&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416946 405262074 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803828 CCN(CCN(C)c1nc(Cl)cc(n1)N(C)C)C(=O)c1ccccc1-n1nccn1 InChI=1S/C20H25ClN8O/c1-5-28(13-12-27(4)20-24-17(21)14-18(25-20)26(2)3)19(30)15-8-6-7-9-16(15)29-22-10-11-23-29/h6-11,14H,5,12-13H2,1-4H3 UFKACZUVRSPVOK-UHFFFAOYSA-N 402084 N-(2-{[4-chloro-6- (dimethylamino)pyrimidin- 2-yl](methyl)amino}ethyl)- N-ethyl-2-(2H-1,2,3-triazol- 2-yl)benzamide::US10011595, E-11 Orexin receptor type 2 Homo sapiens 18.4 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402084 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402084&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121427068 405262075 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803829 CCN(CCN(C)c1nc(Cl)cc(n1)N(C)C)C(=O)c1ccccc1-n1nccn1 InChI=1S/C20H25ClN8O/c1-5-28(13-12-27(4)20-24-17(21)14-18(25-20)26(2)3)19(30)15-8-6-7-9-16(15)29-22-10-11-23-29/h6-11,14H,5,12-13H2,1-4H3 UFKACZUVRSPVOK-UHFFFAOYSA-N 402084 N-(2-{[4-chloro-6- (dimethylamino)pyrimidin- 2-yl](methyl)amino}ethyl)- N-ethyl-2-(2H-1,2,3-triazol- 2-yl)benzamide::US10011595, E-11 Orexin/Hypocretin receptor type 1 Homo sapiens 1145 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402084 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402084&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121427068 405262075 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803830 CCN(CCN(C)c1cccc(n1)C#N)C(=O)c1ccccc1-n1nccn1 InChI=1S/C20H21N7O/c1-3-26(14-13-25(2)19-10-6-7-16(15-21)24-19)20(28)17-8-4-5-9-18(17)27-22-11-12-23-27/h4-12H,3,13-14H2,1-2H3 SPRKOKUPAATSDD-UHFFFAOYSA-N 402085 N-{2-[(6-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(2H-1,2,3-triazol-2- yl)benzamide::US10011595, E-14::US10011595, E-22 Orexin receptor type 2 Homo sapiens 569 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402085 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402085&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416967 405262076 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803831 CCN(CCN(C)c1cccc(n1)C#N)C(=O)c1ccccc1-n1nccn1 InChI=1S/C20H21N7O/c1-3-26(14-13-25(2)19-10-6-7-16(15-21)24-19)20(28)17-8-4-5-9-18(17)27-22-11-12-23-27/h4-12H,3,13-14H2,1-2H3 SPRKOKUPAATSDD-UHFFFAOYSA-N 402085 N-{2-[(6-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(2H-1,2,3-triazol-2- yl)benzamide::US10011595, E-14::US10011595, E-22 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402085 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402085&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416967 405262076 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803832 CCN(CCN(C)c1ncc(Cl)c(n1)C(F)(F)F)C(=O)c1ccccc1-n1nccn1 InChI=1S/C19H19ClF3N7O/c1-3-29(17(31)13-6-4-5-7-15(13)30-25-8-9-26-30)11-10-28(2)18-24-12-14(20)16(27-18)19(21,22)23/h4-9,12H,3,10-11H2,1-2H3 FLIQJZYIHFUSRQ-UHFFFAOYSA-N 402086 N-(2-{[5-chloro-4- (trifluoromethyl)pyrimidin- 2-yl](methyl)amino}ethyl)- N-ethyl-2-(2H-1,2,3-triazol- 2-yl)benzamide::US10011595, E-16 Orexin receptor type 2 Homo sapiens 84.7 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402086 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402086&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121427036 405262077 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803833 CCN(CCN(C)c1ncc(Cl)c(n1)C(F)(F)F)C(=O)c1ccccc1-n1nccn1 InChI=1S/C19H19ClF3N7O/c1-3-29(17(31)13-6-4-5-7-15(13)30-25-8-9-26-30)11-10-28(2)18-24-12-14(20)16(27-18)19(21,22)23/h4-9,12H,3,10-11H2,1-2H3 FLIQJZYIHFUSRQ-UHFFFAOYSA-N 402086 N-(2-{[5-chloro-4- (trifluoromethyl)pyrimidin- 2-yl](methyl)amino}ethyl)- N-ethyl-2-(2H-1,2,3-triazol- 2-yl)benzamide::US10011595, E-16 Orexin/Hypocretin receptor type 1 Homo sapiens 236 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402086 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402086&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121427036 405262077 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803834 CCN(CCN(C)c1cccc(n1)C#N)C(=O)c1ccccc1-n1nccn1 InChI=1S/C20H21N7O/c1-3-26(14-13-25(2)19-10-6-7-16(15-21)24-19)20(28)17-8-4-5-9-18(17)27-22-11-12-23-27/h4-12H,3,13-14H2,1-2H3 SPRKOKUPAATSDD-UHFFFAOYSA-N 402085 N-{2-[(6-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(2H-1,2,3-triazol-2- yl)benzamide::US10011595, E-14::US10011595, E-22 Orexin receptor type 2 Homo sapiens 569 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402085 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402085&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416967 405262076 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803835 CCN(CCN(C)c1cccc(n1)C#N)C(=O)c1ccccc1-n1nccn1 InChI=1S/C20H21N7O/c1-3-26(14-13-25(2)19-10-6-7-16(15-21)24-19)20(28)17-8-4-5-9-18(17)27-22-11-12-23-27/h4-12H,3,13-14H2,1-2H3 SPRKOKUPAATSDD-UHFFFAOYSA-N 402085 N-{2-[(6-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(2H-1,2,3-triazol-2- yl)benzamide::US10011595, E-14::US10011595, E-22 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402085 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402085&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416967 405262076 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803836 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1OC(F)(F)F InChI=1S/C19H19F3N4O2/c1-3-26(11-10-25(2)17-12-14(13-23)8-9-24-17)18(27)15-6-4-5-7-16(15)28-19(20,21)22/h4-9,12H,3,10-11H2,1-2H3 KPYXHCOPWPRIJT-UHFFFAOYSA-N 402088 US10011595, F-1 Orexin receptor type 2 Homo sapiens 58.2 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402088 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402088&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416804 405262078 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803837 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1OC(F)(F)F InChI=1S/C19H19F3N4O2/c1-3-26(11-10-25(2)17-12-14(13-23)8-9-24-17)18(27)15-6-4-5-7-16(15)28-19(20,21)22/h4-9,12H,3,10-11H2,1-2H3 KPYXHCOPWPRIJT-UHFFFAOYSA-N 402088 US10011595, F-1 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402088 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402088&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416804 405262078 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803838 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-c1nnn[nH]1 InChI=1S/C19H20N8O/c1-3-27(11-10-26(2)17-12-14(13-20)8-9-21-17)19(28)16-7-5-4-6-15(16)18-22-24-25-23-18/h4-9,12H,3,10-11H2,1-2H3,(H,22,23,24,25) PWFJZVHKNLAAMM-UHFFFAOYSA-N 402089 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(1H-tetrazol-5- yl)benzamide::US10011595, F-5 Orexin receptor type 2 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402089 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402089&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 146047653 405262079 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803839 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-c1nnn[nH]1 InChI=1S/C19H20N8O/c1-3-27(11-10-26(2)17-12-14(13-20)8-9-21-17)19(28)16-7-5-4-6-15(16)18-22-24-25-23-18/h4-9,12H,3,10-11H2,1-2H3,(H,22,23,24,25) PWFJZVHKNLAAMM-UHFFFAOYSA-N 402089 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(1H-tetrazol-5- yl)benzamide::US10011595, F-5 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402089 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402089&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 146047653 405262079 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803840 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1cccnc1OCc1ccccc1 InChI=1S/C24H25N5O2/c1-3-29(15-14-28(2)22-16-20(17-25)11-13-26-22)24(30)21-10-7-12-27-23(21)31-18-19-8-5-4-6-9-19/h4-13,16H,3,14-15,18H2,1-2H3 JWXOKMAFGCUAQH-UHFFFAOYSA-N 402090 2-(benzyloxy)-N-{2-[(4- cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethylpyridine-3-carboxamide::US10011595, F-6 Orexin receptor type 2 Homo sapiens 97.9 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402090 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402090&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416938 405262080 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803841 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1cccnc1OCc1ccccc1 InChI=1S/C24H25N5O2/c1-3-29(15-14-28(2)22-16-20(17-25)11-13-26-22)24(30)21-10-7-12-27-23(21)31-18-19-8-5-4-6-9-19/h4-13,16H,3,14-15,18H2,1-2H3 JWXOKMAFGCUAQH-UHFFFAOYSA-N 402090 2-(benzyloxy)-N-{2-[(4- cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethylpyridine-3-carboxamide::US10011595, F-6 Orexin/Hypocretin receptor type 1 Homo sapiens 9555 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402090 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402090&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416938 405262080 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803842 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1cccnc1Oc1ccccc1 InChI=1S/C23H23N5O2/c1-3-28(15-14-27(2)21-16-18(17-24)11-13-25-21)23(29)20-10-7-12-26-22(20)30-19-8-5-4-6-9-19/h4-13,16H,3,14-15H2,1-2H3 BXSOTHMRRCLUBX-UHFFFAOYSA-N 402091 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-phenoxypyridine-3- carboxamide::US10011595, F-7 Orexin receptor type 2 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402091 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402091&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416876 405262081 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803843 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1cccnc1Oc1ccccc1 InChI=1S/C23H23N5O2/c1-3-28(15-14-27(2)21-16-18(17-24)11-13-25-21)23(29)20-10-7-12-26-22(20)30-19-8-5-4-6-9-19/h4-13,16H,3,14-15H2,1-2H3 BXSOTHMRRCLUBX-UHFFFAOYSA-N 402091 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-phenoxypyridine-3- carboxamide::US10011595, F-7 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402091 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402091&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416876 405262081 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803844 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1cccnc1C(F)(F)F InChI=1S/C18H18F3N5O/c1-3-26(10-9-25(2)15-11-13(12-22)6-8-23-15)17(27)14-5-4-7-24-16(14)18(19,20)21/h4-8,11H,3,9-10H2,1-2H3 XISCGSWQRNKFRU-UHFFFAOYSA-N 402092 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2- (trifluoromethyl)pyridine-3- carboxamide::US10011595, F-8 Orexin receptor type 2 Homo sapiens 1992 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402092 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402092&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416816 405262082 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803845 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1cccnc1C(F)(F)F InChI=1S/C18H18F3N5O/c1-3-26(10-9-25(2)15-11-13(12-22)6-8-23-15)17(27)14-5-4-7-24-16(14)18(19,20)21/h4-8,11H,3,9-10H2,1-2H3 XISCGSWQRNKFRU-UHFFFAOYSA-N 402092 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2- (trifluoromethyl)pyridine-3- carboxamide::US10011595, F-8 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402092 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402092&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416816 405262082 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803846 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-n1ccnc1 InChI=1S/C21H22N6O/c1-3-26(13-12-25(2)20-14-17(15-22)8-9-24-20)21(28)18-6-4-5-7-19(18)27-11-10-23-16-27/h4-11,14,16H,3,12-13H2,1-2H3 ULSDTCTVGPIMMV-UHFFFAOYSA-N 402093 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(1H-imidazol-1- yl)benzamide::US10011595, F-9 Orexin receptor type 2 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402093 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402093&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416884 405262083 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803847 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-n1ccnc1 InChI=1S/C21H22N6O/c1-3-26(13-12-25(2)20-14-17(15-22)8-9-24-20)21(28)18-6-4-5-7-19(18)27-11-10-23-16-27/h4-11,14,16H,3,12-13H2,1-2H3 ULSDTCTVGPIMMV-UHFFFAOYSA-N 402093 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(1H-imidazol-1- yl)benzamide::US10011595, F-9 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402093 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402093&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416884 405262083 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803848 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1C1(CCOCC1)C#N InChI=1S/C24H27N5O2/c1-3-29(13-12-28(2)22-16-19(17-25)8-11-27-22)23(30)20-6-4-5-7-21(20)24(18-26)9-14-31-15-10-24/h4-8,11,16H,3,9-10,12-15H2,1-2H3 KDRIUCXQLNDKCZ-UHFFFAOYSA-N 402094 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-2-(4- cyanotetrahydro-2H-pyran-4- yl)-N-ethylbenzamide::US10011595, F-10 Orexin receptor type 2 Homo sapiens 7195 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402094 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402094&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416852 405262084 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803849 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1C1(CCOCC1)C#N InChI=1S/C24H27N5O2/c1-3-29(13-12-28(2)22-16-19(17-25)8-11-27-22)23(30)20-6-4-5-7-21(20)24(18-26)9-14-31-15-10-24/h4-8,11,16H,3,9-10,12-15H2,1-2H3 KDRIUCXQLNDKCZ-UHFFFAOYSA-N 402094 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-2-(4- cyanotetrahydro-2H-pyran-4- yl)-N-ethylbenzamide::US10011595, F-10 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402094 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402094&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416852 405262084 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803850 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-c1cnccn1 InChI=1S/C22H22N6O/c1-3-28(13-12-27(2)21-14-17(15-23)8-9-26-21)22(29)19-7-5-4-6-18(19)20-16-24-10-11-25-20/h4-11,14,16H,3,12-13H2,1-2H3 PSSIJKHEXHFQFB-UHFFFAOYSA-N 402095 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-pyrazin-2- ylbenzamide::US10011595, F-11 Orexin receptor type 2 Homo sapiens 23.0 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402095 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402095&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416905 405262085 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803851 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-c1cnccn1 InChI=1S/C22H22N6O/c1-3-28(13-12-27(2)21-14-17(15-23)8-9-26-21)22(29)19-7-5-4-6-18(19)20-16-24-10-11-25-20/h4-11,14,16H,3,12-13H2,1-2H3 PSSIJKHEXHFQFB-UHFFFAOYSA-N 402095 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-pyrazin-2- ylbenzamide::US10011595, F-11 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402095 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402095&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416905 405262085 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803852 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-n1cccn1 InChI=1S/C21H22N6O/c1-3-26(14-13-25(2)20-15-17(16-22)9-11-23-20)21(28)18-7-4-5-8-19(18)27-12-6-10-24-27/h4-12,15H,3,13-14H2,1-2H3 MRANDQUATGNFQM-UHFFFAOYSA-N 402096 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(1H-pyrazol-1- yl)benzamide::US10011595, F-12 Orexin receptor type 2 Homo sapiens 49.6 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402096 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402096&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416923 405262086 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803853 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-n1cccn1 InChI=1S/C21H22N6O/c1-3-26(14-13-25(2)20-15-17(16-22)9-11-23-20)21(28)18-7-4-5-8-19(18)27-12-6-10-24-27/h4-12,15H,3,13-14H2,1-2H3 MRANDQUATGNFQM-UHFFFAOYSA-N 402096 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(1H-pyrazol-1- yl)benzamide::US10011595, F-12 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402096 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402096&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416923 405262086 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803854 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1OCCF InChI=1S/C20H23FN4O2/c1-3-25(12-11-24(2)19-14-16(15-22)8-10-23-19)20(26)17-6-4-5-7-18(17)27-13-9-21/h4-8,10,14H,3,9,11-13H2,1-2H3 ZHLODDFDFVJBGE-UHFFFAOYSA-N 402097 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(2- fluoroethoxy)benzamide::US10011595, F-13 Orexin receptor type 2 Homo sapiens 48.4 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402097 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402097&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416829 405262087 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803855 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1OCCF InChI=1S/C20H23FN4O2/c1-3-25(12-11-24(2)19-14-16(15-22)8-10-23-19)20(26)17-6-4-5-7-18(17)27-13-9-21/h4-8,10,14H,3,9,11-13H2,1-2H3 ZHLODDFDFVJBGE-UHFFFAOYSA-N 402097 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(2- fluoroethoxy)benzamide::US10011595, F-13 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402097 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402097&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416829 405262087 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803856 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1OCC(F)(F)F InChI=1S/C20H21F3N4O2/c1-3-27(11-10-26(2)18-12-15(13-24)8-9-25-18)19(28)16-6-4-5-7-17(16)29-14-20(21,22)23/h4-9,12H,3,10-11,14H2,1-2H3 YTSFRTRPDLFICT-UHFFFAOYSA-N 402098 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(2,2,2- trifluoroethoxy)benzamide::US10011595, F-14 Orexin receptor type 2 Homo sapiens 77.4 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402098 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402098&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 132209825 405262088 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803857 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1OCC(F)(F)F InChI=1S/C20H21F3N4O2/c1-3-27(11-10-26(2)18-12-15(13-24)8-9-25-18)19(28)16-6-4-5-7-17(16)29-14-20(21,22)23/h4-9,12H,3,10-11,14H2,1-2H3 YTSFRTRPDLFICT-UHFFFAOYSA-N 402098 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(2,2,2- trifluoroethoxy)benzamide::US10011595, F-14 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402098 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402098&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 132209825 405262088 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803858 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1c(F)cccc1-n1nccn1 InChI=1S/C20H20FN7O/c1-3-27(12-11-26(2)18-13-15(14-22)7-8-23-18)20(29)19-16(21)5-4-6-17(19)28-24-9-10-25-28/h4-10,13H,3,11-12H2,1-2H3 BSUZVBUCBMVFKV-UHFFFAOYSA-N 402099 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-fluoro-6-(2H-1,2,3- triazol-2-yl)benzamide::US10011595, F-15 Orexin receptor type 2 Homo sapiens 33.9 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402099 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402099&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416975 405262089 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803859 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1c(F)cccc1-n1nccn1 InChI=1S/C20H20FN7O/c1-3-27(12-11-26(2)18-13-15(14-22)7-8-23-18)20(29)19-16(21)5-4-6-17(19)28-24-9-10-25-28/h4-10,13H,3,11-12H2,1-2H3 BSUZVBUCBMVFKV-UHFFFAOYSA-N 402099 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-fluoro-6-(2H-1,2,3- triazol-2-yl)benzamide::US10011595, F-15 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402099 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402099&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416975 405262089 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803860 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1COC InChI=1S/C20H24N4O2/c1-4-24(20(25)18-8-6-5-7-17(18)15-26-3)12-11-23(2)19-13-16(14-21)9-10-22-19/h5-10,13H,4,11-12,15H2,1-3H3 SOKNUDMZILLEAR-UHFFFAOYSA-N 402100 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2- (methoxymethyl)benzamide::US10011595, F-16 Orexin receptor type 2 Homo sapiens 688 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402100 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402100&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416911 405262090 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803861 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1COC InChI=1S/C20H24N4O2/c1-4-24(20(25)18-8-6-5-7-17(18)15-26-3)12-11-23(2)19-13-16(14-21)9-10-22-19/h5-10,13H,4,11-12,15H2,1-3H3 SOKNUDMZILLEAR-UHFFFAOYSA-N 402100 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2- (methoxymethyl)benzamide::US10011595, F-16 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402100 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402100&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416911 405262090 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803862 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1c(F)cccc1-n1ccnn1 InChI=1S/C20H20FN7O/c1-3-27(12-11-26(2)18-13-15(14-22)7-8-23-18)20(29)19-16(21)5-4-6-17(19)28-10-9-24-25-28/h4-10,13H,3,11-12H2,1-2H3 IMIDHDSOQCQDGD-UHFFFAOYSA-N 402101 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-fluoro-6-(1H-1,2,3- triazol-1-yl)benzamide::US10011595, F-17 Orexin receptor type 2 Homo sapiens 945 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402101 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402101&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416904 405262091 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803863 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1c(F)cccc1-n1ccnn1 InChI=1S/C20H20FN7O/c1-3-27(12-11-26(2)18-13-15(14-22)7-8-23-18)20(29)19-16(21)5-4-6-17(19)28-10-9-24-25-28/h4-10,13H,3,11-12H2,1-2H3 IMIDHDSOQCQDGD-UHFFFAOYSA-N 402101 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-fluoro-6-(1H-1,2,3- triazol-1-yl)benzamide::US10011595, F-17 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402101 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402101&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416904 405262091 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803864 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1cccc2[nH]c(=O)oc12 InChI=1S/C19H19N5O3/c1-3-24(10-9-23(2)16-11-13(12-20)7-8-21-16)18(25)14-5-4-6-15-17(14)27-19(26)22-15/h4-8,11H,3,9-10H2,1-2H3,(H,22,26) HFVDFVJHWCQQRC-UHFFFAOYSA-N 402102 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-oxo-2,3-dihydro-1,3- benzoxazole-7-carboxamide::US10011595, F-18 Orexin receptor type 2 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402102 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402102&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416945 405262092 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803865 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1cccc2[nH]c(=O)oc12 InChI=1S/C19H19N5O3/c1-3-24(10-9-23(2)16-11-13(12-20)7-8-21-16)18(25)14-5-4-6-15-17(14)27-19(26)22-15/h4-8,11H,3,9-10H2,1-2H3,(H,22,26) HFVDFVJHWCQQRC-UHFFFAOYSA-N 402102 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-oxo-2,3-dihydro-1,3- benzoxazole-7-carboxamide::US10011595, F-18 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402102 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402102&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416945 405262092 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803866 CCOc1nc2cccc(C(=O)N(CC)CCN(C)c3cc(ccn3)C#N)c2[nH]1 InChI=1S/C21H24N6O2/c1-4-27(12-11-26(3)18-13-15(14-22)9-10-23-18)20(28)16-7-6-8-17-19(16)25-21(24-17)29-5-2/h6-10,13H,4-5,11-12H2,1-3H3,(H,24,25) VEVMQBDGUUTQEY-UHFFFAOYSA-N 402103 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-2- ethoxy-N-ethyl-1H- benzimidazole-7-carboxamide::US10011595, F-19 Orexin receptor type 2 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402103 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402103&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416944 405262093 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803867 CCOc1nc2cccc(C(=O)N(CC)CCN(C)c3cc(ccn3)C#N)c2[nH]1 InChI=1S/C21H24N6O2/c1-4-27(12-11-26(3)18-13-15(14-22)9-10-23-18)20(28)16-7-6-8-17-19(16)25-21(24-17)29-5-2/h6-10,13H,4-5,11-12H2,1-3H3,(H,24,25) VEVMQBDGUUTQEY-UHFFFAOYSA-N 402103 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-2- ethoxy-N-ethyl-1H- benzimidazole-7-carboxamide::US10011595, F-19 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402103 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402103&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416944 405262093 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803868 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C21H23N7O/c1-4-27(12-11-26(3)20-14-17(15-22)7-8-23-20)21(29)18-13-16(2)5-6-19(18)28-24-9-10-25-28/h5-10,13-14H,4,11-12H2,1-3H3 SBOGUZKHMKODTO-UHFFFAOYSA-N 402104 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-5-methyl-2-(2H-1,2,3- triazol-2-yl)benzamide::US10011595, F-20 Orexin receptor type 2 Homo sapiens 16.2 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402104 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402104&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416964 405262094 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803869 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C21H23N7O/c1-4-27(12-11-26(3)20-14-17(15-22)7-8-23-20)21(29)18-13-16(2)5-6-19(18)28-24-9-10-25-28/h5-10,13-14H,4,11-12H2,1-3H3 SBOGUZKHMKODTO-UHFFFAOYSA-N 402104 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-5-methyl-2-(2H-1,2,3- triazol-2-yl)benzamide::US10011595, F-20 Orexin/Hypocretin receptor type 1 Homo sapiens 1621 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402104 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402104&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416964 405262094 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803870 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-n1cc(C)nn1 InChI=1S/C21H23N7O/c1-4-27(12-11-26(3)20-13-17(14-22)9-10-23-20)21(29)18-7-5-6-8-19(18)28-15-16(2)24-25-28/h5-10,13,15H,4,11-12H2,1-3H3 IITRBDGDOXBUGH-UHFFFAOYSA-N 402105 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(4-methyl-1H-1,2,3- triazol-1-yl)benzamide::US10011595, F-21 Orexin receptor type 2 Homo sapiens 341 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402105 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402105&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416961 405262095 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803871 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-n1cc(C)nn1 InChI=1S/C21H23N7O/c1-4-27(12-11-26(3)20-13-17(14-22)9-10-23-20)21(29)18-7-5-6-8-19(18)28-15-16(2)24-25-28/h5-10,13,15H,4,11-12H2,1-3H3 IITRBDGDOXBUGH-UHFFFAOYSA-N 402105 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(4-methyl-1H-1,2,3- triazol-1-yl)benzamide::US10011595, F-21 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402105 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402105&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416961 405262095 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803872 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1N1CCCC1 InChI=1S/C22H27N5O/c1-3-26(15-14-25(2)21-16-18(17-23)10-11-24-21)22(28)19-8-4-5-9-20(19)27-12-6-7-13-27/h4-5,8-11,16H,3,6-7,12-15H2,1-2H3 NZDAWTMXKVVHSH-UHFFFAOYSA-N 402106 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-pyrrolidin-1- ylbenzamide::US10011595, F-22 Orexin receptor type 2 Homo sapiens 31.8 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402106 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402106&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416918 405262096 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803873 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1N1CCCC1 InChI=1S/C22H27N5O/c1-3-26(15-14-25(2)21-16-18(17-23)10-11-24-21)22(28)19-8-4-5-9-20(19)27-12-6-7-13-27/h4-5,8-11,16H,3,6-7,12-15H2,1-2H3 NZDAWTMXKVVHSH-UHFFFAOYSA-N 402106 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-pyrrolidin-1- ylbenzamide::US10011595, F-22 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402106 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402106&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416918 405262096 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803874 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1cccc2oc(=O)[nH]c12 InChI=1S/C19H19N5O3/c1-3-24(10-9-23(2)16-11-13(12-20)7-8-21-16)18(25)14-5-4-6-15-17(14)22-19(26)27-15/h4-8,11H,3,9-10H2,1-2H3,(H,22,26) OQHCCSBWOFYLDC-UHFFFAOYSA-N 402107 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-oxo-2,3-dihydro-1,3- benzoxazole-4-carboxamide::US10011595, F-23 Orexin receptor type 2 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402107 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402107&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 132209830 405262097 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803875 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1cccc2oc(=O)[nH]c12 InChI=1S/C19H19N5O3/c1-3-24(10-9-23(2)16-11-13(12-20)7-8-21-16)18(25)14-5-4-6-15-17(14)22-19(26)27-15/h4-8,11H,3,9-10H2,1-2H3,(H,22,26) OQHCCSBWOFYLDC-UHFFFAOYSA-N 402107 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-oxo-2,3-dihydro-1,3- benzoxazole-4-carboxamide::US10011595, F-23 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402107 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402107&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 132209830 405262097 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803876 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-c1ncc[nH]1 InChI=1S/C21H22N6O/c1-3-27(13-12-26(2)19-14-16(15-22)8-9-23-19)21(28)18-7-5-4-6-17(18)20-24-10-11-25-20/h4-11,14H,3,12-13H2,1-2H3,(H,24,25) UOKDVYMWGWCUBY-UHFFFAOYSA-N 402108 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(1H-imidazol-2- yl)benzamide::US10011595, F-24 Orexin receptor type 2 Homo sapiens 1633 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402108 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402108&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416958 405262098 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803877 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-c1ncc[nH]1 InChI=1S/C21H22N6O/c1-3-27(13-12-26(2)19-14-16(15-22)8-9-23-19)21(28)18-7-5-4-6-17(18)20-24-10-11-25-20/h4-11,14H,3,12-13H2,1-2H3,(H,24,25) UOKDVYMWGWCUBY-UHFFFAOYSA-N 402108 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(1H-imidazol-2- yl)benzamide::US10011595, F-24 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402108 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402108&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416958 405262098 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803878 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-n1cnnn1 InChI=1S/C19H20N8O/c1-3-26(11-10-25(2)18-12-15(13-20)8-9-21-18)19(28)16-6-4-5-7-17(16)27-14-22-23-24-27/h4-9,12,14H,3,10-11H2,1-2H3 MOTDZZQKMCUKKN-UHFFFAOYSA-N 402109 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(1H-tetrazol-1- yl)benzamide::US10011595, F-25 Orexin receptor type 2 Homo sapiens 4390 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402109 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402109&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416977 405262099 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803879 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-n1cnnn1 InChI=1S/C19H20N8O/c1-3-26(11-10-25(2)18-12-15(13-20)8-9-21-18)19(28)16-6-4-5-7-17(16)27-14-22-23-24-27/h4-9,12,14H,3,10-11H2,1-2H3 MOTDZZQKMCUKKN-UHFFFAOYSA-N 402109 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(1H-tetrazol-1- yl)benzamide::US10011595, F-25 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402109 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402109&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416977 405262099 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803880 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1C1(CC1)C#N InChI=1S/C22H23N5O/c1-3-27(13-12-26(2)20-14-17(15-23)8-11-25-20)21(28)18-6-4-5-7-19(18)22(16-24)9-10-22/h4-8,11,14H,3,9-10,12-13H2,1-2H3 ROKJYGISQPVREE-UHFFFAOYSA-N 402110 2-(1-cyanocyclopropyl)-N-{2- [(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethylbenzamide::US10011595, F-26 Orexin receptor type 2 Homo sapiens 18.9 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402110 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402110&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416895 405262100 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803881 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1C1(CC1)C#N InChI=1S/C22H23N5O/c1-3-27(13-12-26(2)20-14-17(15-23)8-11-25-20)21(28)18-6-4-5-7-19(18)22(16-24)9-10-22/h4-8,11,14H,3,9-10,12-13H2,1-2H3 ROKJYGISQPVREE-UHFFFAOYSA-N 402110 2-(1-cyanocyclopropyl)-N-{2- [(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethylbenzamide::US10011595, F-26 Orexin/Hypocretin receptor type 1 Homo sapiens 7711 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402110 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402110&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416895 405262100 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803882 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-c1nc(C)no1 InChI=1S/C21H22N6O2/c1-4-27(12-11-26(3)19-13-16(14-22)9-10-23-19)21(28)18-8-6-5-7-17(18)20-24-15(2)25-29-20/h5-10,13H,4,11-12H2,1-3H3 KNKPQQFJDBLJHU-UHFFFAOYSA-N 402111 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(3-methyl-1,2,4- oxadiazol-5-yl)benzamide::US10011595, F-27 Orexin receptor type 2 Homo sapiens 24.0 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402111 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402111&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416850 405262101 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803883 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-c1nc(C)no1 InChI=1S/C21H22N6O2/c1-4-27(12-11-26(3)19-13-16(14-22)9-10-23-19)21(28)18-8-6-5-7-17(18)20-24-15(2)25-29-20/h5-10,13H,4,11-12H2,1-3H3 KNKPQQFJDBLJHU-UHFFFAOYSA-N 402111 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(3-methyl-1,2,4- oxadiazol-5-yl)benzamide::US10011595, F-27 Orexin/Hypocretin receptor type 1 Homo sapiens 8355 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402111 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402111&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416850 405262101 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803884 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-n1ccnn1 InChI=1S/C20H21N7O/c1-3-26(13-12-25(2)19-14-16(15-21)8-9-22-19)20(28)17-6-4-5-7-18(17)27-11-10-23-24-27/h4-11,14H,3,12-13H2,1-2H3 ZPPFKEJRGOUSEP-UHFFFAOYSA-N 402112 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(1H-1,2,3-triazol-1- yl)benzamide::US10011595, F-28 Orexin receptor type 2 Homo sapiens 461 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402112 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402112&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 132209811 405262102 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803885 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-n1ccnn1 InChI=1S/C20H21N7O/c1-3-26(13-12-25(2)19-14-16(15-21)8-9-22-19)20(28)17-6-4-5-7-18(17)27-11-10-23-24-27/h4-11,14H,3,12-13H2,1-2H3 ZPPFKEJRGOUSEP-UHFFFAOYSA-N 402112 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-(1H-1,2,3-triazol-1- yl)benzamide::US10011595, F-28 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402112 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402112&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 132209811 405262102 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803886 CCOc1cccc(C(=O)N(CC)CCN(C)c2cc(ccn2)C#N)c1OC InChI=1S/C21H26N4O3/c1-5-25(13-12-24(3)19-14-16(15-22)10-11-23-19)21(26)17-8-7-9-18(28-6-2)20(17)27-4/h7-11,14H,5-6,12-13H2,1-4H3 CUAXZEXWMKJYAP-UHFFFAOYSA-N 402113 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-3- ethoxy-N-ethyl-2- methoxybenzamide::US10011595, F-29 Orexin receptor type 2 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402113 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402113&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416867 405262103 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803887 CCOc1cccc(C(=O)N(CC)CCN(C)c2cc(ccn2)C#N)c1OC InChI=1S/C21H26N4O3/c1-5-25(13-12-24(3)19-14-16(15-22)10-11-23-19)21(26)17-8-7-9-18(28-6-2)20(17)27-4/h7-11,14H,5-6,12-13H2,1-4H3 CUAXZEXWMKJYAP-UHFFFAOYSA-N 402113 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-3- ethoxy-N-ethyl-2- methoxybenzamide::US10011595, F-29 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402113 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402113&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416867 405262103 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803888 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1cc(F)ccc1-n1nccn1 InChI=1S/C20H20FN7O/c1-3-27(11-10-26(2)19-12-15(14-22)6-7-23-19)20(29)17-13-16(21)4-5-18(17)28-24-8-9-25-28/h4-9,12-13H,3,10-11H2,1-2H3 SBMSLYQANOITJJ-UHFFFAOYSA-N 402114 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-5-fluoro-2-(2H-1,2,3- triazol-2-yl)benzamide::US10011595, F-30 Orexin receptor type 2 Homo sapiens 24.4 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402114&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 132209813 405262104 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803889 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1cc(F)ccc1-n1nccn1 InChI=1S/C20H20FN7O/c1-3-27(11-10-26(2)19-12-15(14-22)6-7-23-19)20(29)17-13-16(21)4-5-18(17)28-24-8-9-25-28/h4-9,12-13H,3,10-11H2,1-2H3 SBMSLYQANOITJJ-UHFFFAOYSA-N 402114 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-5-fluoro-2-(2H-1,2,3- triazol-2-yl)benzamide::US10011595, F-30 Orexin/Hypocretin receptor type 1 Homo sapiens 9438 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402114&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 132209813 405262104 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803890 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccc(OCC(F)(F)F)nc1 InChI=1S/C19H20F3N5O2/c1-3-27(9-8-26(2)16-10-14(11-23)6-7-24-16)18(28)15-4-5-17(25-12-15)29-13-19(20,21)22/h4-7,10,12H,3,8-9,13H2,1-2H3 ORIACRNKQIIITO-UHFFFAOYSA-N 402115 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-6-(2,2,2- trifluoroethoxy)pyridine-3- carboxamide::US10011595, F-31 Orexin receptor type 2 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402115 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402115&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416894 405262105 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803891 CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccc(OCC(F)(F)F)nc1 InChI=1S/C19H20F3N5O2/c1-3-27(9-8-26(2)16-10-14(11-23)6-7-24-16)18(28)15-4-5-17(25-12-15)29-13-19(20,21)22/h4-7,10,12H,3,8-9,13H2,1-2H3 ORIACRNKQIIITO-UHFFFAOYSA-N 402115 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-6-(2,2,2- trifluoroethoxy)pyridine-3- carboxamide::US10011595, F-31 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402115 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402115&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416894 405262105 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803892 CN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-n1nccn1 InChI=1S/C19H19N7O/c1-24(18-13-15(14-20)7-8-21-18)11-12-25(2)19(27)16-5-3-4-6-17(16)26-22-9-10-23-26/h3-10,13H,11-12H2,1-2H3 JVDGRGUKAYFOKS-UHFFFAOYSA-N 402116 US10011595, G-1 Orexin receptor type 2 Homo sapiens 88.0 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402116 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402116&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416947 405262106 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803893 CN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-n1nccn1 InChI=1S/C19H19N7O/c1-24(18-13-15(14-20)7-8-21-18)11-12-25(2)19(27)16-5-3-4-6-17(16)26-22-9-10-23-26/h3-10,13H,11-12H2,1-2H3 JVDGRGUKAYFOKS-UHFFFAOYSA-N 402116 US10011595, G-1 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402116 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402116&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416947 405262106 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803894 CCCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-n1nccn1 InChI=1S/C21H23N7O/c1-3-12-27(14-13-26(2)20-15-17(16-22)8-9-23-20)21(29)18-6-4-5-7-19(18)28-24-10-11-25-28/h4-11,15H,3,12-14H2,1-2H3 CNLOYQDEQPXFIR-UHFFFAOYSA-N 402117 US10011595, G-4 Orexin receptor type 2 Homo sapiens 12.1 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402117 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402117&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416854 405262107 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803895 CCCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-n1nccn1 InChI=1S/C21H23N7O/c1-3-12-27(14-13-26(2)20-15-17(16-22)8-9-23-20)21(29)18-6-4-5-7-19(18)28-24-10-11-25-28/h4-11,15H,3,12-14H2,1-2H3 CNLOYQDEQPXFIR-UHFFFAOYSA-N 402117 US10011595, G-4 Orexin/Hypocretin receptor type 1 Homo sapiens 1469 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402117 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402117&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416854 405262107 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803896 CCCCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H25N7O/c1-3-4-13-28(15-14-27(2)21-16-18(17-23)9-10-24-21)22(30)19-7-5-6-8-20(19)29-25-11-12-26-29/h5-12,16H,3-4,13-15H2,1-2H3 NZSHKZOIDFHHOD-UHFFFAOYSA-N 402118 US10011595, G-5 Orexin receptor type 2 Homo sapiens 19.8 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402118 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402118&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121427070 405262108 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803897 CCCCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H25N7O/c1-3-4-13-28(15-14-27(2)21-16-18(17-23)9-10-24-21)22(30)19-7-5-6-8-20(19)29-25-11-12-26-29/h5-12,16H,3-4,13-15H2,1-2H3 NZSHKZOIDFHHOD-UHFFFAOYSA-N 402118 US10011595, G-5 Orexin/Hypocretin receptor type 1 Homo sapiens 3214 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402118 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402118&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121427070 405262108 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803898 CN(CCN(Cc1ccccc1)C(=O)c1ccccc1-n1nccn1)c1cc(ccn1)C#N InChI=1S/C25H23N7O/c1-30(24-17-21(18-26)11-12-27-24)15-16-31(19-20-7-3-2-4-8-20)25(33)22-9-5-6-10-23(22)32-28-13-14-29-32/h2-14,17H,15-16,19H2,1H3 RIGOBPYALIWDKJ-UHFFFAOYSA-N 402119 US10011595, G-6 Orexin receptor type 2 Homo sapiens 112 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402119 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402119&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121427022 405262109 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803899 CN(CCN(Cc1ccccc1)C(=O)c1ccccc1-n1nccn1)c1cc(ccn1)C#N InChI=1S/C25H23N7O/c1-30(24-17-21(18-26)11-12-27-24)15-16-31(19-20-7-3-2-4-8-20)25(33)22-9-5-6-10-23(22)32-28-13-14-29-32/h2-14,17H,15-16,19H2,1H3 RIGOBPYALIWDKJ-UHFFFAOYSA-N 402119 US10011595, G-6 Orexin/Hypocretin receptor type 1 Homo sapiens 3855 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402119 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402119&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121427022 405262109 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803900 CN(CCN(CC1CC1)C(=O)c1ccccc1-n1nccn1)c1cc(ccn1)C#N InChI=1S/C22H23N7O/c1-27(21-14-18(15-23)8-9-24-21)12-13-28(16-17-6-7-17)22(30)19-4-2-3-5-20(19)29-25-10-11-26-29/h2-5,8-11,14,17H,6-7,12-13,16H2,1H3 QGAQLKDGGMYDDV-UHFFFAOYSA-N 402120 US10011595, G-7 Orexin receptor type 2 Homo sapiens 35.8 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402120 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402120&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416838 405262110 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803901 CN(CCN(CC1CC1)C(=O)c1ccccc1-n1nccn1)c1cc(ccn1)C#N InChI=1S/C22H23N7O/c1-27(21-14-18(15-23)8-9-24-21)12-13-28(16-17-6-7-17)22(30)19-4-2-3-5-20(19)29-25-10-11-26-29/h2-5,8-11,14,17H,6-7,12-13,16H2,1H3 QGAQLKDGGMYDDV-UHFFFAOYSA-N 402120 US10011595, G-7 Orexin/Hypocretin receptor type 1 Homo sapiens 8426 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402120 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402120&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416838 405262110 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803902 CC(C)CN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H25N7O/c1-17(2)16-28(13-12-27(3)21-14-18(15-23)8-9-24-21)22(30)19-6-4-5-7-20(19)29-25-10-11-26-29/h4-11,14,17H,12-13,16H2,1-3H3 SZCRWPWHBFPVEB-UHFFFAOYSA-N 402121 US10011595, G-8 Orexin receptor type 2 Homo sapiens 12.2 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402121 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402121&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416931 405262111 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803903 CC(C)CN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H25N7O/c1-17(2)16-28(13-12-27(3)21-14-18(15-23)8-9-24-21)22(30)19-6-4-5-7-20(19)29-25-10-11-26-29/h4-11,14,17H,12-13,16H2,1-3H3 SZCRWPWHBFPVEB-UHFFFAOYSA-N 402121 US10011595, G-8 Orexin/Hypocretin receptor type 1 Homo sapiens 1178 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402121 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402121&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416931 405262111 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803904 CC(C)N(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-n1nccn1 InChI=1S/C21H23N7O/c1-16(2)27(13-12-26(3)20-14-17(15-22)8-9-23-20)21(29)18-6-4-5-7-19(18)28-24-10-11-25-28/h4-11,14,16H,12-13H2,1-3H3 FNNMSTSAVXFDJQ-UHFFFAOYSA-N 402122 US10011595, G-9 Orexin receptor type 2 Homo sapiens 76.5 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402122 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402122&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416881 405262112 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803905 CC(C)N(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-n1nccn1 InChI=1S/C21H23N7O/c1-16(2)27(13-12-26(3)20-14-17(15-22)8-9-23-20)21(29)18-6-4-5-7-19(18)28-24-10-11-25-28/h4-11,14,16H,12-13H2,1-3H3 FNNMSTSAVXFDJQ-UHFFFAOYSA-N 402122 US10011595, G-9 Orexin/Hypocretin receptor type 1 Homo sapiens 9196 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402122 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402122&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416881 405262112 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803906 CN(CCN(CC(F)(F)F)C(=O)c1ccccc1-n1nccn1)c1cc(ccn1)C#N InChI=1S/C20H18F3N7O/c1-28(18-12-15(13-24)6-7-25-18)10-11-29(14-20(21,22)23)19(31)16-4-2-3-5-17(16)30-26-8-9-27-30/h2-9,12H,10-11,14H2,1H3 MNLGJARFXAMQNM-UHFFFAOYSA-N 402123 US10011595, G-10 Orexin receptor type 2 Homo sapiens 113 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402123 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402123&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416899 405262113 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803907 CN(CCN(CC(F)(F)F)C(=O)c1ccccc1-n1nccn1)c1cc(ccn1)C#N InChI=1S/C20H18F3N7O/c1-28(18-12-15(13-24)6-7-25-18)10-11-29(14-20(21,22)23)19(31)16-4-2-3-5-17(16)30-26-8-9-27-30/h2-9,12H,10-11,14H2,1H3 MNLGJARFXAMQNM-UHFFFAOYSA-N 402123 US10011595, G-10 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402123 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402123&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416899 405262113 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803908 CCN(CC(NC)c1nccc(n1)C(C)(C)O)C(=O)c1ccccc1-n1nccn1 InChI=1S/C21H27N7O2/c1-5-27(14-16(22-4)19-23-11-10-18(26-19)21(2,3)30)20(29)15-8-6-7-9-17(15)28-24-12-13-25-28/h6-13,16,22,30H,5,14H2,1-4H3 CPJXORATLMHDPZ-UHFFFAOYSA-N 402124 US10011595, H-1 Orexin receptor type 2 Homo sapiens 11.0 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402124 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402124&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 146047654 405262114 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803909 CCN(CC(NC)c1nccc(n1)C(C)(C)O)C(=O)c1ccccc1-n1nccn1 InChI=1S/C21H27N7O2/c1-5-27(14-16(22-4)19-23-11-10-18(26-19)21(2,3)30)20(29)15-8-6-7-9-17(15)28-24-12-13-25-28/h6-13,16,22,30H,5,14H2,1-4H3 CPJXORATLMHDPZ-UHFFFAOYSA-N 402124 US10011595, H-1 Orexin/Hypocretin receptor type 1 Homo sapiens 4070 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402124 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402124&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 146047654 405262114 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803910 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1cccnc1OC(C)C InChI=1S/C21H31N5O3/c1-7-26(19(27)16-9-8-11-22-18(16)29-15(2)3)14-13-25(6)20-23-12-10-17(24-20)21(4,5)28/h8-12,15,28H,7,13-14H2,1-6H3 IBJOSCHWGCACFL-UHFFFAOYSA-N 402125 US10011595, H-14 Orexin receptor type 2 Homo sapiens 65.4 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402125&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416862 405262115 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803911 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1cccnc1OC(C)C InChI=1S/C21H31N5O3/c1-7-26(19(27)16-9-8-11-22-18(16)29-15(2)3)14-13-25(6)20-23-12-10-17(24-20)21(4,5)28/h8-12,15,28H,7,13-14H2,1-6H3 IBJOSCHWGCACFL-UHFFFAOYSA-N 402125 US10011595, H-14 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402125&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416862 405262115 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803912 CCOc1ncccc1C(=O)N(CC)CCN(C)c1nccc(n1)C(C)(C)O InChI=1S/C20H29N5O3/c1-6-25(18(26)15-9-8-11-21-17(15)28-7-2)14-13-24(5)19-22-12-10-16(23-19)20(3,4)27/h8-12,27H,6-7,13-14H2,1-5H3 MLYDNIIDGFOHJE-UHFFFAOYSA-N 402126 2-ethoxy-N-ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl) nicotinamide::US10011595, H-15 Orexin receptor type 2 Homo sapiens 77.3 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402126 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402126&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416825 405262116 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803913 CCOc1ncccc1C(=O)N(CC)CCN(C)c1nccc(n1)C(C)(C)O InChI=1S/C20H29N5O3/c1-6-25(18(26)15-9-8-11-21-17(15)28-7-2)14-13-24(5)19-22-12-10-16(23-19)20(3,4)27/h8-12,27H,6-7,13-14H2,1-5H3 MLYDNIIDGFOHJE-UHFFFAOYSA-N 402126 2-ethoxy-N-ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl) nicotinamide::US10011595, H-15 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402126 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402126&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416825 405262116 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803914 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1cccnc1OCC(F)F InChI=1S/C20H27F2N5O3/c1-5-27(18(28)14-7-6-9-23-17(14)30-13-16(21)22)12-11-26(4)19-24-10-8-15(25-19)20(2,3)29/h6-10,16,29H,5,11-13H2,1-4H3 PAWCWJGVSZQEKW-UHFFFAOYSA-N 402127 2-(2,2-difluoroethoxy)-N- ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl) nicotinamide::US10011595, H-16 Orexin receptor type 2 Homo sapiens 24.2 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402127 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402127&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416879 405262117 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803915 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1cccnc1OCC(F)F InChI=1S/C20H27F2N5O3/c1-5-27(18(28)14-7-6-9-23-17(14)30-13-16(21)22)12-11-26(4)19-24-10-8-15(25-19)20(2,3)29/h6-10,16,29H,5,11-13H2,1-4H3 PAWCWJGVSZQEKW-UHFFFAOYSA-N 402127 2-(2,2-difluoroethoxy)-N- ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl) nicotinamide::US10011595, H-16 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402127 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402127&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416879 405262117 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803916 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1cccnc1OCC(F)(F)F InChI=1S/C20H26F3N5O3/c1-5-28(12-11-27(4)18-25-10-8-15(26-18)19(2,3)30)17(29)14-7-6-9-24-16(14)31-13-20(21,22)23/h6-10,30H,5,11-13H2,1-4H3 VSUWHVJCEFGMCX-UHFFFAOYSA-N 402128 2-(2,2-difluoroethoxy)-N- ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl) nicotinamide::US10011595, H-17 Orexin receptor type 2 Homo sapiens 21.7 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402128 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402128&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121427075 405262118 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803917 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1cccnc1OCC(F)(F)F InChI=1S/C20H26F3N5O3/c1-5-28(12-11-27(4)18-25-10-8-15(26-18)19(2,3)30)17(29)14-7-6-9-24-16(14)31-13-20(21,22)23/h6-10,30H,5,11-13H2,1-4H3 VSUWHVJCEFGMCX-UHFFFAOYSA-N 402128 2-(2,2-difluoroethoxy)-N- ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl) nicotinamide::US10011595, H-17 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402128 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402128&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121427075 405262118 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803918 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1ccccc1OC(F)F InChI=1S/C20H26F2N4O3/c1-5-26(17(27)14-8-6-7-9-15(14)29-18(21)22)13-12-25(4)19-23-11-10-16(24-19)20(2,3)28/h6-11,18,28H,5,12-13H2,1-4H3 LIWRAEIDMGUICE-UHFFFAOYSA-N 402129 2-(difluoromethoxy)-N-ethyl- N-(2-((4-(2-hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl) benzamide::US10011595, H-18 Orexin receptor type 2 Homo sapiens 49.3 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402129 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402129&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416933 405262119 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803919 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1ccccc1OC(F)F InChI=1S/C20H26F2N4O3/c1-5-26(17(27)14-8-6-7-9-15(14)29-18(21)22)13-12-25(4)19-23-11-10-16(24-19)20(2,3)28/h6-11,18,28H,5,12-13H2,1-4H3 LIWRAEIDMGUICE-UHFFFAOYSA-N 402129 2-(difluoromethoxy)-N-ethyl- N-(2-((4-(2-hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl) benzamide::US10011595, H-18 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402129 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402129&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416933 405262119 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803920 CCCc1ccccc1C(=O)N(CC)CCN(C)c1nccc(n1)C(C)(C)O InChI=1S/C22H32N4O2/c1-6-10-17-11-8-9-12-18(17)20(27)26(7-2)16-15-25(5)21-23-14-13-19(24-21)22(3,4)28/h8-9,11-14,28H,6-7,10,15-16H2,1-5H3 JBMBCLVPWFNBPO-UHFFFAOYSA-N 402130 N-ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl)-2- propylbenzamide::US10011595, H-19 Orexin receptor type 2 Homo sapiens 13.1 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402130 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402130&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416853 405262120 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803921 CCCc1ccccc1C(=O)N(CC)CCN(C)c1nccc(n1)C(C)(C)O InChI=1S/C22H32N4O2/c1-6-10-17-11-8-9-12-18(17)20(27)26(7-2)16-15-25(5)21-23-14-13-19(24-21)22(3,4)28/h8-9,11-14,28H,6-7,10,15-16H2,1-5H3 JBMBCLVPWFNBPO-UHFFFAOYSA-N 402130 N-ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl)-2- propylbenzamide::US10011595, H-19 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402130 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402130&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416853 405262120 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803922 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1ccccc1OCC(F)(F)F InChI=1S/C21H27F3N4O3/c1-5-28(13-12-27(4)19-25-11-10-17(26-19)20(2,3)30)18(29)15-8-6-7-9-16(15)31-14-21(22,23)24/h6-11,30H,5,12-14H2,1-4H3 RHNREHFQUWKTCA-UHFFFAOYSA-N 402131 N-ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl)-2- (2,2,2- trifluoroethoxy)benzamide::US10011595, H-20 Orexin receptor type 2 Homo sapiens 32.0 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402131 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402131&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121427078 405262121 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803923 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1ccccc1OCC(F)(F)F InChI=1S/C21H27F3N4O3/c1-5-28(13-12-27(4)19-25-11-10-17(26-19)20(2,3)30)18(29)15-8-6-7-9-16(15)31-14-21(22,23)24/h6-11,30H,5,12-14H2,1-4H3 RHNREHFQUWKTCA-UHFFFAOYSA-N 402131 N-ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl)-2- (2,2,2- trifluoroethoxy)benzamide::US10011595, H-20 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402131 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402131&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121427078 405262121 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803924 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1ccccc1CC(F)(F)F InChI=1S/C21H27F3N4O2/c1-5-28(18(29)16-9-7-6-8-15(16)14-21(22,23)24)13-12-27(4)19-25-11-10-17(26-19)20(2,3)30/h6-11,30H,5,12-14H2,1-4H3 FNBAOLZCHOIAMR-UHFFFAOYSA-N 402132 N-ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl)-2- (2,2,2- trifluoroethyl)benzamide::US10011595, H-21 Orexin receptor type 2 Homo sapiens 18.0 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402132 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402132&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121427076 405262122 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803925 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1ccccc1CC(F)(F)F InChI=1S/C21H27F3N4O2/c1-5-28(18(29)16-9-7-6-8-15(16)14-21(22,23)24)13-12-27(4)19-25-11-10-17(26-19)20(2,3)30/h6-11,30H,5,12-14H2,1-4H3 FNBAOLZCHOIAMR-UHFFFAOYSA-N 402132 N-ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl)-2- (2,2,2- trifluoroethyl)benzamide::US10011595, H-21 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402132 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402132&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121427076 405262122 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803926 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1ccccc1OCC(F)F InChI=1S/C21H28F2N4O3/c1-5-27(19(28)15-8-6-7-9-16(15)30-14-18(22)23)13-12-26(4)20-24-11-10-17(25-20)21(2,3)29/h6-11,18,29H,5,12-14H2,1-4H3 DTXSXSQFRWAZRY-UHFFFAOYSA-N 402133 2-(2,2-difluoroethoxy)-N- ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl) benzamide::US10011595, H-22 Orexin receptor type 2 Homo sapiens 17.7 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402133 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402133&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416866 405262123 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803927 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1ccccc1OCC(F)F InChI=1S/C21H28F2N4O3/c1-5-27(19(28)15-8-6-7-9-16(15)30-14-18(22)23)13-12-26(4)20-24-11-10-17(25-20)21(2,3)29/h6-11,18,29H,5,12-14H2,1-4H3 DTXSXSQFRWAZRY-UHFFFAOYSA-N 402133 2-(2,2-difluoroethoxy)-N- ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl) benzamide::US10011595, H-22 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402133 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402133&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416866 405262123 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803928 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1cccnc1CC(F)(F)F InChI=1S/C20H26F3N5O2/c1-5-28(17(29)14-7-6-9-24-15(14)13-20(21,22)23)12-11-27(4)18-25-10-8-16(26-18)19(2,3)30/h6-10,30H,5,11-13H2,1-4H3 WNHOUZGTOJGLAN-UHFFFAOYSA-N 402134 N-ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl)-2- (2,2,2- trifluoroethyl)nicotinamide::US10011595, H-23 Orexin receptor type 2 Homo sapiens 179 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402134 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402134&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121427038 405262124 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803929 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1cccnc1CC(F)(F)F InChI=1S/C20H26F3N5O2/c1-5-28(17(29)14-7-6-9-24-15(14)13-20(21,22)23)12-11-27(4)18-25-10-8-16(26-18)19(2,3)30/h6-10,30H,5,11-13H2,1-4H3 WNHOUZGTOJGLAN-UHFFFAOYSA-N 402134 N-ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl)-2- (2,2,2- trifluoroethyl)nicotinamide::US10011595, H-23 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402134 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402134&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121427038 405262124 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803930 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1ccccc1CC(F)F InChI=1S/C21H28F2N4O2/c1-5-27(19(28)16-9-7-6-8-15(16)14-18(22)23)13-12-26(4)20-24-11-10-17(25-20)21(2,3)29/h6-11,18,29H,5,12-14H2,1-4H3 YMAWLTYAGRGBNI-UHFFFAOYSA-N 402135 2-(2,2-difluoroethyl)-N-ethyl- N-(2-((4-(2-hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl) benzamide::US10011595, H-24 Orexin receptor type 2 Homo sapiens 20.6 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402135&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416863 405262125 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803931 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1ccccc1CC(F)F InChI=1S/C21H28F2N4O2/c1-5-27(19(28)16-9-7-6-8-15(16)14-18(22)23)13-12-26(4)20-24-11-10-17(25-20)21(2,3)29/h6-11,18,29H,5,12-14H2,1-4H3 YMAWLTYAGRGBNI-UHFFFAOYSA-N 402135 2-(2,2-difluoroethyl)-N-ethyl- N-(2-((4-(2-hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl) benzamide::US10011595, H-24 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402135&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416863 405262125 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803932 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1ccccc1C1CC1 InChI=1S/C22H30N4O2/c1-5-26(20(27)18-9-7-6-8-17(18)16-10-11-16)15-14-25(4)21-23-13-12-19(24-21)22(2,3)28/h6-9,12-13,16,28H,5,10-11,14-15H2,1-4H3 KPVIGDZRTLDILG-UHFFFAOYSA-N 402136 2-cyclopropyl-N-ethyl-N-(2- ((4-(2-hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl) benzamide::US10011595, H-25 Orexin receptor type 2 Homo sapiens 9.10 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402136 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402136&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416839 405262126 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803933 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1ccccc1C1CC1 InChI=1S/C22H30N4O2/c1-5-26(20(27)18-9-7-6-8-17(18)16-10-11-16)15-14-25(4)21-23-13-12-19(24-21)22(2,3)28/h6-9,12-13,16,28H,5,10-11,14-15H2,1-4H3 KPVIGDZRTLDILG-UHFFFAOYSA-N 402136 2-cyclopropyl-N-ethyl-N-(2- ((4-(2-hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl) benzamide::US10011595, H-25 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402136 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402136&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416839 405262126 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803934 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1ccccc1C1CC1(F)F InChI=1S/C22H28F2N4O2/c1-5-28(13-12-27(4)20-25-11-10-18(26-20)21(2,3)30)19(29)16-9-7-6-8-15(16)17-14-22(17,23)24/h6-11,17,30H,5,12-14H2,1-4H3 ZIZSDKRUEPCQET-UHFFFAOYSA-N 402137 2-(2,2-difluorocyclopropyl)- N-ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl) benzamide::US10011595, H-26 Orexin receptor type 2 Homo sapiens 16.9 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402137 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402137&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416877 405262127 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803935 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1ccccc1C1CC1(F)F InChI=1S/C22H28F2N4O2/c1-5-28(13-12-27(4)20-25-11-10-18(26-20)21(2,3)30)19(29)16-9-7-6-8-15(16)17-14-22(17,23)24/h6-11,17,30H,5,12-14H2,1-4H3 ZIZSDKRUEPCQET-UHFFFAOYSA-N 402137 2-(2,2-difluorocyclopropyl)- N-ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl) benzamide::US10011595, H-26 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402137 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402137&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416877 405262127 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803936 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1ccccc1OC(F)(F)F InChI=1S/C20H25F3N4O3/c1-5-27(17(28)14-8-6-7-9-15(14)30-20(21,22)23)13-12-26(4)18-24-11-10-16(25-18)19(2,3)29/h6-11,29H,5,12-13H2,1-4H3 CQPDKUSLEHJDGW-UHFFFAOYSA-N 402138 N-ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyridin-2- yl)(methyl)amino)ethyl)-2- (trifluoromethoxy)benzamide::US10011595, H-27 Orexin receptor type 2 Homo sapiens 10.00 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402138 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402138&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416864 405262128 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803937 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1ccccc1OC(F)(F)F InChI=1S/C20H25F3N4O3/c1-5-27(17(28)14-8-6-7-9-15(14)30-20(21,22)23)13-12-26(4)18-24-11-10-16(25-18)19(2,3)29/h6-11,29H,5,12-13H2,1-4H3 CQPDKUSLEHJDGW-UHFFFAOYSA-N 402138 N-ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyridin-2- yl)(methyl)amino)ethyl)-2- (trifluoromethoxy)benzamide::US10011595, H-27 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402138 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402138&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416864 405262128 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803938 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1ccc(OC)nc1C1CC1 InChI=1S/C22H31N5O3/c1-6-27(14-13-26(4)21-23-12-11-17(24-21)22(2,3)29)20(28)16-9-10-18(30-5)25-19(16)15-7-8-15/h9-12,15,29H,6-8,13-14H2,1-5H3 QFGYEOCXSCFDKR-UHFFFAOYSA-N 402139 2-cyclopropyl-N-ethyl-N-(2- ((4-(2-hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl)-6- methoxynicotinamide::US10011595, H-28 Orexin receptor type 2 Homo sapiens 20.0 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402139 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402139&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416824 405262129 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803939 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1ccc(OC)nc1C1CC1 InChI=1S/C22H31N5O3/c1-6-27(14-13-26(4)21-23-12-11-17(24-21)22(2,3)29)20(28)16-9-10-18(30-5)25-19(16)15-7-8-15/h9-12,15,29H,6-8,13-14H2,1-5H3 QFGYEOCXSCFDKR-UHFFFAOYSA-N 402139 2-cyclopropyl-N-ethyl-N-(2- ((4-(2-hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl)-6- methoxynicotinamide::US10011595, H-28 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402139 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402139&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416824 405262129 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803940 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1ccccc1-n1ncnn1 InChI=1S/C20H26N8O2/c1-5-27(13-12-26(4)19-21-11-10-17(24-19)20(2,3)30)18(29)15-8-6-7-9-16(15)28-23-14-22-25-28/h6-11,14,30H,5,12-13H2,1-4H3 TXENDFXVXHYNDY-UHFFFAOYSA-N 402140 N-ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl)-2- (2H-tetrazol-2-yl)benzamide::US10011595, H-29 Orexin receptor type 2 Homo sapiens 17.0 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402140 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402140&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416857 405262130 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803941 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1ccccc1-n1ncnn1 InChI=1S/C20H26N8O2/c1-5-27(13-12-26(4)19-21-11-10-17(24-19)20(2,3)30)18(29)15-8-6-7-9-16(15)28-23-14-22-25-28/h6-11,14,30H,5,12-13H2,1-4H3 TXENDFXVXHYNDY-UHFFFAOYSA-N 402140 N-ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl)-2- (2H-tetrazol-2-yl)benzamide::US10011595, H-29 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402140 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402140&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416857 405262130 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803942 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1cccnc1-c1ccccc1 InChI=1S/C24H29N5O2/c1-5-29(17-16-28(4)23-26-15-13-20(27-23)24(2,3)31)22(30)19-12-9-14-25-21(19)18-10-7-6-8-11-18/h6-15,31H,5,16-17H2,1-4H3 XLYIQPOCIBZCNY-UHFFFAOYSA-N 402141 N-ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl)-2- phenylnicotinamide::US10011595, H-30 Orexin receptor type 2 Homo sapiens 53.0 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402141 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402141&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416811 405262131 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803943 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1cccnc1-c1ccccc1 InChI=1S/C24H29N5O2/c1-5-29(17-16-28(4)23-26-15-13-20(27-23)24(2,3)31)22(30)19-12-9-14-25-21(19)18-10-7-6-8-11-18/h6-15,31H,5,16-17H2,1-4H3 XLYIQPOCIBZCNY-UHFFFAOYSA-N 402141 N-ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl)-2- phenylnicotinamide::US10011595, H-30 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402141 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402141&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416811 405262131 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803944 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1ncccc1-c1ccccc1 InChI=1S/C24H29N5O2/c1-5-29(17-16-28(4)23-26-15-13-20(27-23)24(2,3)31)22(30)21-19(12-9-14-25-21)18-10-7-6-8-11-18/h6-15,31H,5,16-17H2,1-4H3 XTJVFLLXMZCHNV-UHFFFAOYSA-N 402142 N-ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl)-3- phenylpicolinamide::US10011595, H-31 Orexin receptor type 2 Homo sapiens 23.0 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402142 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402142&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416939 405262132 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803945 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1ncccc1-c1ccccc1 InChI=1S/C24H29N5O2/c1-5-29(17-16-28(4)23-26-15-13-20(27-23)24(2,3)31)22(30)21-19(12-9-14-25-21)18-10-7-6-8-11-18/h6-15,31H,5,16-17H2,1-4H3 XTJVFLLXMZCHNV-UHFFFAOYSA-N 402142 N-ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl)-3- phenylpicolinamide::US10011595, H-31 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402142 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402142&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416939 405262132 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803946 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1nccnc1-n1cccn1 InChI=1S/C20H26N8O2/c1-5-27(14-13-26(4)19-23-9-7-15(25-19)20(2,3)30)18(29)16-17(22-11-10-21-16)28-12-6-8-24-28/h6-12,30H,5,13-14H2,1-4H3 OUEBMPOZKNJOMP-UHFFFAOYSA-N 402143 N-ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl)-3- (1H-pyrazol-1-yl)pyrazine-2- carboxamide::US10011595, H-32 Orexin receptor type 2 Homo sapiens 54.0 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402143 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402143&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416921 405262133 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803947 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1nccnc1-n1cccn1 InChI=1S/C20H26N8O2/c1-5-27(14-13-26(4)19-23-9-7-15(25-19)20(2,3)30)18(29)16-17(22-11-10-21-16)28-12-6-8-24-28/h6-12,30H,5,13-14H2,1-4H3 OUEBMPOZKNJOMP-UHFFFAOYSA-N 402143 N-ethyl-N-(2-((4-(2- hydroxypropan-2- yl)pyrimidin-2- yl)(methyl)amino)ethyl)-3- (1H-pyrazol-1-yl)pyrazine-2- carboxamide::US10011595, H-32 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402143 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402143&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416921 405262133 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803948 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1cccnc1-n1cccn1 InChI=1S/C21H27N7O2/c1-5-27(15-14-26(4)20-23-12-9-17(25-20)21(2,3)30)19(29)16-8-6-10-22-18(16)28-13-7-11-24-28/h6-13,30H,5,14-15H2,1-4H3 NEYDZNIQOUUJJZ-UHFFFAOYSA-N 402144 N-ethyl-N-[2-[[4-(1-hydroxy- 1-methyl-ethyl)pyrimidin-2- yl]-methyl-amino]ethyl]-2- pyrazol-1-yl-pyridine-3- carboxamide::US10011595, H-33 Orexin receptor type 2 Homo sapiens 37.0 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402144 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402144&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416875 405262134 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803949 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1cccnc1-n1cccn1 InChI=1S/C21H27N7O2/c1-5-27(15-14-26(4)20-23-12-9-17(25-20)21(2,3)30)19(29)16-8-6-10-22-18(16)28-13-7-11-24-28/h6-13,30H,5,14-15H2,1-4H3 NEYDZNIQOUUJJZ-UHFFFAOYSA-N 402144 N-ethyl-N-[2-[[4-(1-hydroxy- 1-methyl-ethyl)pyrimidin-2- yl]-methyl-amino]ethyl]-2- pyrazol-1-yl-pyridine-3- carboxamide::US10011595, H-33 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402144 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402144&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416875 405262134 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803950 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1ncccc1-n1nccn1 InChI=1S/C20H26N8O2/c1-5-27(14-13-26(4)19-22-10-8-16(25-19)20(2,3)30)18(29)17-15(7-6-9-21-17)28-23-11-12-24-28/h6-12,30H,5,13-14H2,1-4H3 UFGVWLQKOFBMJL-UHFFFAOYSA-N 402145 N-ethyl-N-[2-[[4-(1-hydroxy- 1-methyl-ethyl)pyrimidin-2- yl]-methyl-amino]ethyl]-3- (triazol-2-yl)pyridine-2- carboxamide::US10011595, H-34 Orexin receptor type 2 Homo sapiens 43.0 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402145 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402145&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416892 405262135 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803951 CCN(CCN(C)c1nccc(n1)C(C)(C)O)C(=O)c1ncccc1-n1nccn1 InChI=1S/C20H26N8O2/c1-5-27(14-13-26(4)19-22-10-8-16(25-19)20(2,3)30)18(29)17-15(7-6-9-21-17)28-23-11-12-24-28/h6-12,30H,5,13-14H2,1-4H3 UFGVWLQKOFBMJL-UHFFFAOYSA-N 402145 N-ethyl-N-[2-[[4-(1-hydroxy- 1-methyl-ethyl)pyrimidin-2- yl]-methyl-amino]ethyl]-3- (triazol-2-yl)pyridine-2- carboxamide::US10011595, H-34 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402145 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402145&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416892 405262135 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803952 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H28N6O2/c1-5-27(16-15-26(4)20-12-8-11-19(25-20)22(2,3)30)21(29)17-9-6-7-10-18(17)28-23-13-14-24-28/h6-14,30H,5,15-16H2,1-4H3 DQNDADHDXKZQQZ-UHFFFAOYSA-N 402147 US10011595, I-1 Orexin receptor type 2 Homo sapiens 12.4 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402147 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402147&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416809 405262137 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803953 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H28N6O2/c1-5-27(16-15-26(4)20-12-8-11-19(25-20)22(2,3)30)21(29)17-9-6-7-10-18(17)28-23-13-14-24-28/h6-14,30H,5,15-16H2,1-4H3 DQNDADHDXKZQQZ-UHFFFAOYSA-N 402147 US10011595, I-1 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402147 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402147&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416809 405262137 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803954 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1ccccc1OCC(F)F InChI=1S/C22H29F2N3O3/c1-5-27(21(28)16-9-6-7-10-17(16)30-15-19(23)24)14-13-26(4)20-12-8-11-18(25-20)22(2,3)29/h6-12,19,29H,5,13-15H2,1-4H3 PTJNGZHULGZPDE-UHFFFAOYSA-N 402148 US10011595, I-4 Orexin receptor type 2 Homo sapiens 179 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402148 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402148&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416865 405262138 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803955 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1ccccc1OCC(F)F InChI=1S/C22H29F2N3O3/c1-5-27(21(28)16-9-6-7-10-17(16)30-15-19(23)24)14-13-26(4)20-12-8-11-18(25-20)22(2,3)29/h6-12,19,29H,5,13-15H2,1-4H3 PTJNGZHULGZPDE-UHFFFAOYSA-N 402148 US10011595, I-4 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402148 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402148&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416865 405262138 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803956 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1ncccc1-n1nccn1 InChI=1S/C21H27N7O2/c1-5-27(15-14-26(4)18-10-6-9-17(25-18)21(2,3)30)20(29)19-16(8-7-11-22-19)28-23-12-13-24-28/h6-13,30H,5,14-15H2,1-4H3 BVCWWOHSXWXVOE-UHFFFAOYSA-N 402149 N-ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)-3-(2H- 1,2,3-triazol-2-yl)picolinamide::US10011595, I-9 Orexin receptor type 2 Homo sapiens 312 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402149&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121427037 405262139 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803957 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1ncccc1-n1nccn1 InChI=1S/C21H27N7O2/c1-5-27(15-14-26(4)18-10-6-9-17(25-18)21(2,3)30)20(29)19-16(8-7-11-22-19)28-23-12-13-24-28/h6-13,30H,5,14-15H2,1-4H3 BVCWWOHSXWXVOE-UHFFFAOYSA-N 402149 N-ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)-3-(2H- 1,2,3-triazol-2-yl)picolinamide::US10011595, I-9 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402149&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121427037 405262139 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803958 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1ccccc1-n1cccn1 InChI=1S/C23H29N5O2/c1-5-27(17-16-26(4)21-13-8-12-20(25-21)23(2,3)30)22(29)18-10-6-7-11-19(18)28-15-9-14-24-28/h6-15,30H,5,16-17H2,1-4H3 VJOHXQPFIPDCJH-UHFFFAOYSA-N 402150 N-ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)-2-(1H- pyrazol-1-yl)benzamide::US10011595, I-10 Orexin receptor type 2 Homo sapiens 93.3 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402150 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402150&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416942 405262140 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803959 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1ccccc1-n1cccn1 InChI=1S/C23H29N5O2/c1-5-27(17-16-26(4)21-13-8-12-20(25-21)23(2,3)30)22(29)18-10-6-7-11-19(18)28-15-9-14-24-28/h6-15,30H,5,16-17H2,1-4H3 VJOHXQPFIPDCJH-UHFFFAOYSA-N 402150 N-ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)-2-(1H- pyrazol-1-yl)benzamide::US10011595, I-10 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402150 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402150&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416942 405262140 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803960 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1nccnc1-n1cccn1 InChI=1S/C21H27N7O2/c1-5-27(15-14-26(4)17-9-6-8-16(25-17)21(2,3)30)20(29)18-19(23-12-11-22-18)28-13-7-10-24-28/h6-13,30H,5,14-15H2,1-4H3 XJWQHPRCNHGOGD-UHFFFAOYSA-N 402151 N-ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)-3-(1H- pyrazol-1-yl)pyrazine-2- carboxamide::US10011595, I-11 Orexin receptor type 2 Homo sapiens 328 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402151 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402151&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416962 405262141 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803961 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1nccnc1-n1cccn1 InChI=1S/C21H27N7O2/c1-5-27(15-14-26(4)17-9-6-8-16(25-17)21(2,3)30)20(29)18-19(23-12-11-22-18)28-13-7-10-24-28/h6-13,30H,5,14-15H2,1-4H3 XJWQHPRCNHGOGD-UHFFFAOYSA-N 402151 N-ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)-3-(1H- pyrazol-1-yl)pyrazine-2- carboxamide::US10011595, I-11 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402151 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402151&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416962 405262141 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803962 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1ccccc1OC(F)(F)F InChI=1S/C21H26F3N3O3/c1-5-27(19(28)15-9-6-7-10-16(15)30-21(22,23)24)14-13-26(4)18-12-8-11-17(25-18)20(2,3)29/h6-12,29H,5,13-14H2,1-4H3 BVIPNAJTTULRTM-UHFFFAOYSA-N 402152 N-ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)-2- (trifluoromethoxy)benzamide::US10011595, I-12 Orexin receptor type 2 Homo sapiens 73.7 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402152&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416851 405262142 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803963 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1ccccc1OC(F)(F)F InChI=1S/C21H26F3N3O3/c1-5-27(19(28)15-9-6-7-10-16(15)30-21(22,23)24)14-13-26(4)18-12-8-11-17(25-18)20(2,3)29/h6-12,29H,5,13-14H2,1-4H3 BVIPNAJTTULRTM-UHFFFAOYSA-N 402152 N-ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)-2- (trifluoromethoxy)benzamide::US10011595, I-12 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402152&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416851 405262142 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803964 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1ccccc1C1CC1 InChI=1S/C23H31N3O2/c1-5-26(22(27)19-10-7-6-9-18(19)17-13-14-17)16-15-25(4)21-12-8-11-20(24-21)23(2,3)28/h6-12,17,28H,5,13-16H2,1-4H3 JORIDSPEJHMTAF-UHFFFAOYSA-N 402153 2-cyclopropyl-N-ethyl-N-(2- ((6-(2-hydroxypropan-2- yl)pyridin-2- yl)(methyl)amino)ethyl)benz- amide::US10011595, I-13 Orexin receptor type 2 Homo sapiens 53.7 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402153 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402153&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416814 405262143 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803965 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1ccccc1C1CC1 InChI=1S/C23H31N3O2/c1-5-26(22(27)19-10-7-6-9-18(19)17-13-14-17)16-15-25(4)21-12-8-11-20(24-21)23(2,3)28/h6-12,17,28H,5,13-16H2,1-4H3 JORIDSPEJHMTAF-UHFFFAOYSA-N 402153 2-cyclopropyl-N-ethyl-N-(2- ((6-(2-hydroxypropan-2- yl)pyridin-2- yl)(methyl)amino)ethyl)benz- amide::US10011595, I-13 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402153 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402153&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416814 405262143 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803966 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1ccccc1OC(F)F InChI=1S/C21H27F2N3O3/c1-5-26(19(27)15-9-6-7-10-16(15)29-20(22)23)14-13-25(4)18-12-8-11-17(24-18)21(2,3)28/h6-12,20,28H,5,13-14H2,1-4H3 BWCJQXVNCAOSRY-UHFFFAOYSA-N 402154 2-(difluoromethoxy)-N-ethyl- N-(2-((6-(2-hydroxypropan-2- yl)pyridin-2- yl)(methyl)amino)ethyl)benz- amide::US10011595, I-14 Orexin receptor type 2 Homo sapiens 201 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402154 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402154&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416888 405262144 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803967 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1ccccc1OC(F)F InChI=1S/C21H27F2N3O3/c1-5-26(19(27)15-9-6-7-10-16(15)29-20(22)23)14-13-25(4)18-12-8-11-17(24-18)21(2,3)28/h6-12,20,28H,5,13-14H2,1-4H3 BWCJQXVNCAOSRY-UHFFFAOYSA-N 402154 2-(difluoromethoxy)-N-ethyl- N-(2-((6-(2-hydroxypropan-2- yl)pyridin-2- yl)(methyl)amino)ethyl)benz- amide::US10011595, I-14 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402154 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402154&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416888 405262144 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803968 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1cccnc1OCC(F)(F)F InChI=1S/C21H27F3N4O3/c1-5-28(13-12-27(4)17-10-6-9-16(26-17)20(2,3)30)19(29)15-8-7-11-25-18(15)31-14-21(22,23)24/h6-11,30H,5,12-14H2,1-4H3 RTQNJZJAKXGBPA-UHFFFAOYSA-N 402155 N-ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)-2- (2,2,2- trifluoroethoxy)nicotinamide::US10011595, I-15 Orexin receptor type 2 Homo sapiens 306 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402155 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402155&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416834 405262145 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803969 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1cccnc1OCC(F)(F)F InChI=1S/C21H27F3N4O3/c1-5-28(13-12-27(4)17-10-6-9-16(26-17)20(2,3)30)19(29)15-8-7-11-25-18(15)31-14-21(22,23)24/h6-11,30H,5,12-14H2,1-4H3 RTQNJZJAKXGBPA-UHFFFAOYSA-N 402155 N-ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)-2- (2,2,2- trifluoroethoxy)nicotinamide::US10011595, I-15 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402155 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402155&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416834 405262145 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803970 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1cccnc1OCC(F)F InChI=1S/C21H28F2N4O3/c1-5-27(20(28)15-8-7-11-24-19(15)30-14-17(22)23)13-12-26(4)18-10-6-9-16(25-18)21(2,3)29/h6-11,17,29H,5,12-14H2,1-4H3 VOWSBEFWRYHDQF-UHFFFAOYSA-N 402156 2-(2,2-difluoroethoxy)-N-ethyl- N-(2-((6-(2-hydroxypropan-2- yl)pyridin-2- yl)(methyl)amino)ethyl)nicotin- amide::US10011595, I-16 Orexin receptor type 2 Homo sapiens 234 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402156 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402156&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416836 405262146 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803971 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1cccnc1OCC(F)F InChI=1S/C21H28F2N4O3/c1-5-27(20(28)15-8-7-11-24-19(15)30-14-17(22)23)13-12-26(4)18-10-6-9-16(25-18)21(2,3)29/h6-11,17,29H,5,12-14H2,1-4H3 VOWSBEFWRYHDQF-UHFFFAOYSA-N 402156 2-(2,2-difluoroethoxy)-N-ethyl- N-(2-((6-(2-hydroxypropan-2- yl)pyridin-2- yl)(methyl)amino)ethyl)nicotin- amide::US10011595, I-16 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402156 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402156&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416836 405262146 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803972 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1ccccc1OCC(F)(F)F InChI=1S/C22H28F3N3O3/c1-5-28(14-13-27(4)19-12-8-11-18(26-19)21(2,3)30)20(29)16-9-6-7-10-17(16)31-15-22(23,24)25/h6-12,30H,5,13-15H2,1-4H3 IUMWZNCXRYLEQW-UHFFFAOYSA-N 402157 N-ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)-2- (2,2,2- trifluoroethoxy)benzamide::US10011595, I-17 Orexin receptor type 2 Homo sapiens 326 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402157 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402157&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416883 405262147 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803973 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1ccccc1OCC(F)(F)F InChI=1S/C22H28F3N3O3/c1-5-28(14-13-27(4)19-12-8-11-18(26-19)21(2,3)30)20(29)16-9-6-7-10-17(16)31-15-22(23,24)25/h6-12,30H,5,13-15H2,1-4H3 IUMWZNCXRYLEQW-UHFFFAOYSA-N 402157 N-ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)-2- (2,2,2- trifluoroethoxy)benzamide::US10011595, I-17 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402157 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402157&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416883 405262147 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803974 CCOc1ccccc1C(=O)N(CC)CCN(C)c1cccc(n1)C(C)(C)O InChI=1S/C22H31N3O3/c1-6-25(21(26)17-11-8-9-12-18(17)28-7-2)16-15-24(5)20-14-10-13-19(23-20)22(3,4)27/h8-14,27H,6-7,15-16H2,1-5H3 VLVIANIHYWAKNB-UHFFFAOYSA-N 402158 2-ethoxy-N-ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)benz- amide::US10011595, I-18 Orexin receptor type 2 Homo sapiens 154 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402158&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 132209794 405262148 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803975 CCOc1ccccc1C(=O)N(CC)CCN(C)c1cccc(n1)C(C)(C)O InChI=1S/C22H31N3O3/c1-6-25(21(26)17-11-8-9-12-18(17)28-7-2)16-15-24(5)20-14-10-13-19(23-20)22(3,4)27/h8-14,27H,6-7,15-16H2,1-5H3 VLVIANIHYWAKNB-UHFFFAOYSA-N 402158 2-ethoxy-N-ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)benz- amide::US10011595, I-18 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402158&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 132209794 405262148 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803976 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1cccnc1CC(F)(F)F InChI=1S/C21H27F3N4O2/c1-5-28(19(29)15-8-7-11-25-16(15)14-21(22,23)24)13-12-27(4)18-10-6-9-17(26-18)20(2,3)30/h6-11,30H,5,12-14H2,1-4H3 IYJFCMIDHUENES-UHFFFAOYSA-N 402159 N-ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)-2- (2,2,2- trifluoroethyl)nicotinamide::US10011595, I-19 Orexin receptor type 2 Homo sapiens 2266 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402159 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402159&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416935 405262149 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803977 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1cccnc1CC(F)(F)F InChI=1S/C21H27F3N4O2/c1-5-28(19(29)15-8-7-11-25-16(15)14-21(22,23)24)13-12-27(4)18-10-6-9-17(26-18)20(2,3)30/h6-11,30H,5,12-14H2,1-4H3 IYJFCMIDHUENES-UHFFFAOYSA-N 402159 N-ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)-2- (2,2,2- trifluoroethyl)nicotinamide::US10011595, I-19 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402159 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402159&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416935 405262149 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803978 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1ccccc1C1CC1(F)F InChI=1S/C23H29F2N3O2/c1-5-28(14-13-27(4)20-12-8-11-19(26-20)22(2,3)30)21(29)17-10-7-6-9-16(17)18-15-23(18,24)25/h6-12,18,30H,5,13-15H2,1-4H3 BHHGYLYAIGDHDQ-UHFFFAOYSA-N 402160 2-(2,2-difluorocyclopropyl)-N- ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)benz- amide::US10011595, I-20 Orexin receptor type 2 Homo sapiens 36.4 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402160 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402160&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416808 405262150 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803979 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1ccccc1C1CC1(F)F InChI=1S/C23H29F2N3O2/c1-5-28(14-13-27(4)20-12-8-11-19(26-20)22(2,3)30)21(29)17-10-7-6-9-16(17)18-15-23(18,24)25/h6-12,18,30H,5,13-15H2,1-4H3 BHHGYLYAIGDHDQ-UHFFFAOYSA-N 402160 2-(2,2-difluorocyclopropyl)-N- ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)benz- amide::US10011595, I-20 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402160 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402160&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416808 405262150 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803980 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1cccnc1OC(C)C InChI=1S/C22H32N4O3/c1-7-26(21(27)17-10-9-13-23-20(17)29-16(2)3)15-14-25(6)19-12-8-11-18(24-19)22(4,5)28/h8-13,16,28H,7,14-15H2,1-6H3 JMUFAAMOHYSPSU-UHFFFAOYSA-N 402161 N-ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)-2- isopropoxynicotinamide::US10011595, I-21 Orexin receptor type 2 Homo sapiens 387 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402161&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416936 405262151 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803981 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1cccnc1OC(C)C InChI=1S/C22H32N4O3/c1-7-26(21(27)17-10-9-13-23-20(17)29-16(2)3)15-14-25(6)19-12-8-11-18(24-19)22(4,5)28/h8-13,16,28H,7,14-15H2,1-6H3 JMUFAAMOHYSPSU-UHFFFAOYSA-N 402161 N-ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)-2- isopropoxynicotinamide::US10011595, I-21 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402161&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416936 405262151 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803982 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1ncccc1-c1ccccc1 InChI=1S/C25H30N4O2/c1-5-29(18-17-28(4)22-15-9-14-21(27-22)25(2,3)31)24(30)23-20(13-10-16-26-23)19-11-7-6-8-12-19/h6-16,31H,5,17-18H2,1-4H3 LVUOPPODOZBPTH-UHFFFAOYSA-N 402162 N-ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)-3- phenylpicolinamide::US10011595, I-22 Orexin receptor type 2 Homo sapiens 211 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402162&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416934 405262152 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803983 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1ncccc1-c1ccccc1 InChI=1S/C25H30N4O2/c1-5-29(18-17-28(4)22-15-9-14-21(27-22)25(2,3)31)24(30)23-20(13-10-16-26-23)19-11-7-6-8-12-19/h6-16,31H,5,17-18H2,1-4H3 LVUOPPODOZBPTH-UHFFFAOYSA-N 402162 N-ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)-3- phenylpicolinamide::US10011595, I-22 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402162&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416934 405262152 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803984 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1ccccc1-n1ncnn1 InChI=1S/C21H27N7O2/c1-5-27(14-13-26(4)19-12-8-11-18(24-19)21(2,3)30)20(29)16-9-6-7-10-17(16)28-23-15-22-25-28/h6-12,15,30H,5,13-14H2,1-4H3 JMOVEDDRYRZKGL-UHFFFAOYSA-N 402163 N-ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)-2-(2H- tetrazol-2-yl)benzamide::US10011595, I-23 Orexin receptor type 2 Homo sapiens 69.6 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402163 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402163&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416913 405262153 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803985 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1ccccc1-n1ncnn1 InChI=1S/C21H27N7O2/c1-5-27(14-13-26(4)19-12-8-11-18(24-19)21(2,3)30)20(29)16-9-6-7-10-17(16)28-23-15-22-25-28/h6-12,15,30H,5,13-14H2,1-4H3 JMOVEDDRYRZKGL-UHFFFAOYSA-N 402163 N-ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)-2-(2H- tetrazol-2-yl)benzamide::US10011595, I-23 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402163 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402163&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416913 405262153 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803986 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1cccnc1-n1cccn1 InChI=1S/C22H28N6O2/c1-5-27(16-15-26(4)19-11-6-10-18(25-19)22(2,3)30)21(29)17-9-7-12-23-20(17)28-14-8-13-24-28/h6-14,30H,5,15-16H2,1-4H3 LJUJFSKHXLMOOP-UHFFFAOYSA-N 402164 N-ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)-2-(1H- pyrazol-1-yl)nicotinamide::US10011595, I-24 Orexin receptor type 2 Homo sapiens 104 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402164 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402164&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416869 405262154 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803987 CCN(CCN(C)c1cccc(n1)C(C)(C)O)C(=O)c1cccnc1-n1cccn1 InChI=1S/C22H28N6O2/c1-5-27(16-15-26(4)19-11-6-10-18(25-19)22(2,3)30)21(29)17-9-7-12-23-20(17)28-14-8-13-24-28/h6-14,30H,5,15-16H2,1-4H3 LJUJFSKHXLMOOP-UHFFFAOYSA-N 402164 N-ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)-2-(1H- pyrazol-1-yl)nicotinamide::US10011595, I-24 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402164 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402164&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416869 405262154 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 803988 CCOc1ncccc1C(=O)N(CC)CCN(C)c1cccc(n1)C(C)(C)O InChI=1S/C21H30N4O3/c1-6-25(20(26)16-10-9-13-22-19(16)28-7-2)15-14-24(5)18-12-8-11-17(23-18)21(3,4)27/h8-13,27H,6-7,14-15H2,1-5H3 NTKGNDNKHIDWKA-UHFFFAOYSA-N 402165 2-ethoxy-N-ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)nicotin- amide::US10011595, I-25 Orexin receptor type 2 Homo sapiens 466 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402165 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402165&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121416907 405262155 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 803989 CCOc1ncccc1C(=O)N(CC)CCN(C)c1cccc(n1)C(C)(C)O InChI=1S/C21H30N4O3/c1-6-25(20(26)16-10-9-13-22-19(16)28-7-2)15-14-24(5)18-12-8-11-17(23-18)21(3,4)27/h8-13,27H,6-7,14-15H2,1-5H3 NTKGNDNKHIDWKA-UHFFFAOYSA-N 402165 2-ethoxy-N-ethyl-N-(2-((6-(2- hydroxypropan-2-yl)pyridin-2- yl)(methyl)amino)ethyl)nicotin- amide::US10011595, I-25 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q20R9RS1 aid1799329 US10011595 Kim, RM; Kuduk, SD; Liverton, N; Zhou, G 7/3/2018 5/26/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=402165 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=402165&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121416907 405262155 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6